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Two coronaviruses (CoVs)—severe acute respiratory syndrome (SARS) virus and 
Middle East respiratory syndrome (MERS) virus—have emerged in the 21st century from animal 
reservoirs into the human population, each causing an epidemic associated with significant 
disease and mortality. CoV epidemics are currently only controllable by rigorous public health 
measures; no targeted therapeutics or vaccines exist to treat or prevent any human CoV infection. 
One method of generating attenuated CoV strains to be studied as vaccine candidates involves 
specifically disrupting CoV-encoded interferon (IFN) antagonists, thereby rendering the virus 
vulnerable to host innate antiviral immunity. Deubiquitinating (DUB) activity encoded within 
CoV nonstructural protein (nsp) 3 and endoribonuclease (EndoU) activity encoded within nsp15 
are both reported to suppress IFN-mediated antiviral immunity during infection. Using murine 
hepatitis virus (MHV) as a model CoV, we generated viruses that encode enzymatically deficient 
forms of these proteins and have shown that EndoU-mutant- and DUB-mutant-MHV elicit 
significantly increased type I IFN responses relative to the parental wild type (WT) strain. 
However, despite similar patterns of IFN induction by both mutant viruses, we previously found 
that only the EndoU-mut virus is attenuated and does not cause detectable disease in mice, 
whereas DUB-mut-MHV is not attenuated in vivo and causes disease similar to WT-MHV. The 
purpose of this project was to investigate the host transcriptional response to infection with 
EndoU-mut-, DUB-mut-, and WT-MHV in primary murine macrophages using RNA-sequencing 
 (RNA-seq) technology to examine the cellular dynamics that underlie the remarkably distinct 
phenotypes of EndoU-mut- and DUB-mut-MHV infections in mice.
xv
The results of our RNA-seq experiments and subsequent bioinformatic analyses 
demonstrate that WT-MHV infection led to profound transcriptional dysregulation of hundreds 
of host genes, many of which encode proteins that are involved in inflammation, antiviral 
defense, signaling pathways, and transcription regulation. DUB-mut-MHV elicited a statistically 
indistinguishable transcriptional response of all but a select few genes relative to WT-MHV. In 
stark contrast, EndoU-mut-MHV-infected cells exhibited markedly diminished transcription of 
the vast majority of genes that were induced by DUB-mut- and WT-MHV, leading to a 
profoundly distinct transcriptional response overall. Both EndoU-mut- and DUB-mut-MHV 
induced significantly higher expression of multiple type I IFN isoforms relative to the WT virus, 
with the EndoU-mut strain prompting a dramatically higher IFN response than even the DUB-
mut virus. Together, the results of this work suggest that the induction of IFN alone is not a 
sufficient marker for mutant CoV attenuation or of widespread dysregulation of host gene 
expression in the context of studying interferon antagonist-deficient coronavirus strains; rather, 
the magnitude and timing of IFN expression are critical. We conclude that there is a threshold of 
interferon expression that must be crossed before a host macrophage mounts a differential 
response to an IFN antagonist-deficient coronavirus that is capable of limiting the infection. 
Furthermore, we propose that MHV encodes a hierarchy of IFN antagonists that suppress and/or 
evade the host immune response in different ways and to different degrees. The results of this 
project advance what is known about how coronavirus-encoded IFN antagonists fine-tune the 
host response to viral infection and we hope that this work will guide future studies involving 




Coronaviruses Are Important and Diverse Pathogens
Recent outbreaks of the Middle East respiratory syndrome (MERS) virus (2012-present) 
and the severe acute respiratory syndrome (SARS) virus (2002-2004) demonstrated that 
coronaviruses (CoVs) can emerge from animal reservoirs to pose significant threats to human 
populations worldwide. Four other CoVs—HCoV-229E, -OC43, -NL63, and -HKU1—are 
known to infect the human population and generally cause relatively mild, self-limiting cold 
symptoms in immunocompetent individuals but can lead to lethal disease in children and 
immunocompromised or immunosuppressed patients (Dijkman and van der Hoek 2009; Gaunt et 
al. 2010). Both SARS-CoV and MERS-CoV cause highly lethal respiratory disease in their 
hosts: about 35-40% of patients infected with MERS-CoV, and about 10% of patients infected 
with SARS-CoV, died during the course of each respective outbreak (Hui et al. 2014). 
Importantly, these epidemics were controlled only by virtue of public health initiatives and strict 
quarantine protocols. At present, no vaccines or specific antivirals are available for the 
prevention or treatment of any CoV infection, which is cause for concern given the possibility of 
a novel, lethal CoV akin to SARS-CoV or MERS-CoV emerging into the human population in 
the future. Without such therapies, the human immune system alone seems to be inherently 
inefficient in staving off CoV replication and pathogenesis, rendering the host vulnerable to 
severe coronaviral disease (Perlman and Netland 2009; de Wit et al. 2016).
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Depicted in Figure 1 is a phylogenetic tree of 50 CoVs within the Coronavirinae 
subfamily of the Coronaviridae order. All of these viruses assemble into virions that share the 
same basic structural morphology, which features a “corona” (halo) of spike (S) proteins for 
which the family is named (Figure 2) (Almeida and Tyrrell 1967; Virology: Coronaviruses 
1968). The Coronaviridae subfamily includes, in addition to human-tropic viruses, a host of 
other CoVs that infect and cause disease in a variety of animal species, including cattle, swine, 
mice, cats, and others. Several of these animal CoVs, such as bovine coronavirus (BCV) and 
porcine epidemic diarrhea virus (PEDV), wreak economic havoc on the agriculture industries of 
developed nations like China and the United States by causing infections and fatalities among 
millions of calves and piglets (Cho and Yoon 2014; Lee 2015; Sunniva Oma et al. 2016). Other 
animal CoVs—feline infectious peritonitis virus (FIPV), for example—are important veterinary 
viruses because they cause untreatable and often lethal infections in animals that are kept as pets 
(Pedersen 2014). Murine hepatitis coronavirus (MHV), which is in the same genus as SARS- and 
MERS-CoV and is commonly used in biomedical research as a mouse model for human CoV 
infections, is used in the study described herein. Collectively, several members of the 
Coronaviridae subfamily pose serious threats to human populations due to their abilities to act as 
direct human pathogens (SARS-CoV, MERS-CoV, etc.), impact our food supply by devastating 
the agriculture industry (BCV, PEDV, etc.), and even cause disease in our domesticated pets 
(FIPV). It is critical, therefore, that we study how these viruses interact with their hosts and 
identify the factors that make them such successful pathogens throughout the animal kingdom. 
The ultimate goal of such research is to develop vaccines and targeted antivirals that we can use 
to protect ourselves from current CoV strains as well as from novel strains that may emerge in 
the future.
18
Figure 1. Phylogenetic Tree of the Coronaviridae Subamily. Phylogenetic tree depicting 50 
CoVs, organized by genus (-, -, -, and -CoVs) and lineage (-CoV A, B, C, and D). This 
tree was constructed by Chan et al. (2015) based on partial nucleotide sequences of the RNA-
dependent RNA polymerase encoded by each virus. The scale bar represents the degree of 
sequence identity—via the estimated number of substitutions within the RdRp per 20 
nucleotides—as a measure of relationship between viruses. Red arrows denote the 6 CoVs that 
infect humans; black arrow denotes the murine hepatitis virus (MHV) that was used as a model 
CoV in the experiments described herein. Modified with permission from Chan et al. (2015).
19
Figure 2. Typical Structure of a Coronavirus Virion. Coronaviruses form spherical, 
enveloped virions, each of which encloses a single copy of the positive-sense single-stranded 
RNA (ssRNA) viral genome. Encapsulating and protecting the viral genome are nucleocapsid 
(N) proteins. Viral envelope (E), membrane (M), and spike (S) proteins integrate into the host-
derived envelope. S proteins form a “crown” around each virion that is readily discernible by 
electron microscopy. Used with permission from Perlman and Netland (2009).
The Type I Interferon Response
One key factor that contributes to the inefficient human immune response to CoV 
infections, and therefore to the success of coronaviruses as pathogens, is the impressive ability of 
these viruses to evade and/or antagonize the type I interferon (IFN) response, an antiviral process 
that falls under the umbrella of innate immunity (Perlman and Netland 2009; Zhou et al. 2014; 
de Wit et al. 2016). Type I IFNs, which include IFN- and IFN-, are signaling molecules that 
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act as a first line of defense against viral pathogens and some non-viral intracellular infections 
(Bogdan et al. 2004; Ivashkiv and Donlin 2014). These cytokines are expressed by a variety of 
cell types in response to the detection of pathogen-associated molecular patterns (PAMPs) by 
cellular pathogen recognition receptors (PRRs), as illustrated in Figure 3. For the recognition of 
viruses, relevant PRRs include Toll-like receptors (TLRs) 3, 7/8, and 9; RIG-I-like receptors 
(RLRs) RIG-I and MDA-5; and the protein kinase R (PKR) and 2′-5′ oligoadenylate synthetase 
(OAS)/RNase L systems (Hsu et al. 2004; Thompson et al. 2011). These receptors, which are 
shared between mice and humans, recognize 3 main types of viral PAMPs: double-stranded 
RNA (dsRNA), single-stranded RNA (ssRNA) in endosomes, and cytoplasmic DNA. Upon 
activation by PAMPs, many PRRs initiate signaling pathways that culminate in the induction of 
IFN and other genes. Shown in Figure 3, once IFNs are translated, cleaved, and secreted, they act 
in an autocrine and paracrine manner to induce an antiviral state within infected and neighboring 
cells through signaling pathways that terminate in the expression of antiviral IFN-stimulated 
genes (ISGs) (Haller et al. 2006; Ivashkiv and Donlin 2014). The canonical signaling pathway 
for the type I IFNs through the interferon- receptor (IFNAR) is depicted in Figure 4. Many of 
the ISGs and inflammatory genes that are expressed as a consequence of IFN signaling restrict 
the virus by impeding the replication and expression of the viral genome, halting translation, 
inducing apoptosis, initiating inflammation, and a number of other processes that collectively 
combat the viral infection (Haller et al. 2006; Schoggins and Rice 2011; Schneider et al. 2014). 
Type I IFNs are also crucial activators of innate immune cells like macrophages and natural 
killer cells, which participate in coordinating the immune response, phagocytosing apoptotic 
virus-infected cells, and killing virus-infected cells (Fujimoto et al. 2000; Paolini et al. 2015). 
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Finally, type I IFNs can enhance the adaptive immune response to viral infections by augmenting 
the functions of B and T cells (Ivashkiv and Donlin 2014).
Figure 3. The type I IFN Response to Viral Infection. The IFN response is initiated when viral 
pathogen-associated patterns (PAMPs) are detected by host pattern recognition receptors (PRRs) 
(red arrows) in infected cells. Upon activation of PRRs, non-immune cells such as epithelial cells 
and fibroblasts (top left) express and secrete type I IFN- (yellow circles), which act as signaling 
molecules in a paracrine and autocrine fashion to induce an antiviral state within infected and 
uninfected host cells. This antiviral state is achieved as a consequence of IFN signaling, which 
induces the expression of IFN-stimulated genes (ISGs) that act in a variety of ways to counteract 
the viral life cycle. Additionally, immune cells such as macrophages and dendritic cells (DCs) 
(bottom) secrete large amounts of type I IFN- and IFN- (orange and yellow circles, 
respectively) upon PRR activation, which contribute to the innate and adaptive antiviral response 
by inducing the expression of ISGs in host cells, increasing the production of chemokines to 
attract antiviral immune cells including macrophages and natural killer cells, and enhancing the 
activities of B and T cells. Modified with permission from Ivashkiv and Donlin (2014).
22
Figure 4. Canonical Type I IFN Signaling Pathway through the IFN- Receptor. Type I 
IFN- and IFN- bind the type I IFN- receptor (IFNAR) on infected and uninfected cells and 
initiate signaling cascades that terminate in the expression of ISGs (OAS, MX1, IRF1, etc.), 
inflammatory molecules (CXCL9, etc.), and regulators of the inflammatory response. Shown are 
the 3 primary signaling cascades that comprise the canonical type I IFN signaling pathway. Used 
with permission from Ivashkiv and Donlin (2014).
In summary, the type I IFN response lies at the foundation of our bodies’ ability to 
combat a viral infection. It is therefore no surprise that many viruses, including CoVs, have 
evolved a variety of means to escape, dysregulate, and/or antagonize the IFN induction and 
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signaling pathways at various points in order to ensure that their replication and dissemination 
within the host remain unchecked (Schulz and Mossman 2016). Figure 5 illustrates a number of 
known strategies, many of which are achieved by CoV proteins (indicated with red arrows), that 
viruses employ to counteract the induction of IFN expression. It is critical that we study the 
diverse mechanisms through which CoVs disrupt the antiviral innate immune response so that 
we might guide the development therapeutics and vaccines that can be used to enhance the 
ability of our immune system to successfully clear a coronaviral infection.
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Figure 5. Viral Strategies for Evading and Antagonizing IFN Induction. Most viruses 
encode at least one factor that acts to antagonize and/or evade the activation of the signaling 
pathways that initiate the expression of type I IFN (grey circles) during infection. Shown are 
some of these viruses, including several coronaviruses and CoV-encoded factors (indicated with 
red arrows), and the respective step(s) at which they act to suppress the induction of IFN. 
Modified with permission from Schulz and Mossman (2016).
CoV-encoded IFN Antagonists
Coronaviruses are particularly successful at potently dysregulating the IFN and 
subsequent ISG responses during infection, thereby enabling these viruses to evade clearance by 
the host’s immune system (Cheung et al. 2005; Frieman et al. 2009; Menachery et al. 2014; 
Deng et al. 2017; Kindler et al. 2017). In particular, it is increasingly clear that CoVs delay the 
IFN and ISG responses during infection, which ultimately contributes to unchecked viral 
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replication and the development of disease (Menachery et al. 2014; Channappanavar et al. 2016). 
In their study using a mouse-adapted strain of human SARS-CoV, Channappanavar et al. (2016) 
found that treating SARS-CoV-infected mice with exogenous type I IFN early during infection at 
6 hpi completely protected the mice from weight loss and clinical disease, whereas infected mice 
treated with type I IFN at 24 hpi experienced weight loss and succumbed to clinical disease at 
the same rate as untreated infected mice. These results, which are depicted schematically in 
Figure 6, demonstrated that the timing of the IFN response is critical in determining the outcome 
of a CoV infection and suggest that CoVs are capable of delaying IFN expression until a point in 
time when it is no longer sufficient to curb viral replication or clinical disease. Therefore, 
understanding the mechanism(s) by which CoVs achieve this delay in the IFN response might 
reveal strategies for combatting coronaviral disease.
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Figure 6. CoVs Delay the Type I IFN Response. (Bottom) Mice infected with a mouse-adapted 
strain of SARS-CoV exhibited a delay in the induction of the type I IFN response (blue curves) 
during infection, which contributed to high viral titer (green curves) and lethal disease (orange 
curves). (Top) Treatment of SARS-CoV-infected mice with type I IFN early during infection led 
to an earlier type I IFN response, which in turn was associated with moderately reduced viral 
titer, significant reduction in clinical disease, and mouse survival. This experiment suggests that 
CoVs delay the type I IFN response during infection, thereby identifying coronavirus-mediated 
IFN antagonism as a target for the development of vaccines and antiviral therapeutics. Modified 
with permission from Channappanavar et al. (2016).
Coronaviruses possess the largest genomes of all RNA viruses (ranging from 
approximately 27-32 kilobases, depending on the particular virus), which encode many structural 
and nonstructural proteins (nsps), as illustrated for MHV in Figure 7 (Gorbalenya et al. 2006). 
Many CoV-nsps are known to participate in the replication process of the virus, depicted in 
Figure 8, as components of viral replication complexes within virus-induced double-membrane 
vesicles (DMVs) (Gosert et al. 2002; Knoops et al. 2008). Previous studies from our lab and 





other groups revealed that several murine and human coronavirus structural and nonstructural 
proteins, albeit encoding markedly different enzymatic and structural properties, also participate 
in IFN antagonism during infection (Frieman et al. 2009; Schulz and Mossman 2016; Deng et al. 
2017; Kindler et al. 2017). Two of these proteins—nsp3 and nsp15—were the focus of the 
project herein using MHV-A59 as a model coronavirus.
Figure 7. Schematic diagram of EndoU-mut, DUB-mut, and WT-MHV genomes. Illustration 
of the annotated genomes for WT-MHV A59 parental strain (Top), EndoU-mut- (Middle), and 
DUB-mut-MHV (Bottom). Structural, nonstructural, and accessory proteins are colored salmon, 
green, and blue, respectively. Mutations in EndoU-mut- and DUB-mut-MHV are listed below 
the target nsps (red boxes). Modified with permission from Deng et al. (2017).
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Figure 8. Life Cycle of a Typical CoV. Coronaviruses bind their respective cellular receptors 
via their S proteins (pink, top left). Upon entering the host cell by endocytosis, the viral envelope 
fuses with the membrane of the host endosome, releasing the viral genome. The genome is 
subsequently translated by host machinery into viral polyproteins pp1a and pp1ab, which are 
then cleaved into their constituent nsps by viral proteases (center left). The nsps comprise the 
viral replicase machinery (in the form of replication complexes), which is housed in host-derived 
DMVs (center bottom). Replication complexes coordinate transcription of the positive-sense 
viral genome into negative-sense RNAs, which are then either replicated and packaged into 
virions to be released as infectious particles (right), or reverse-transcribed into a nested set of 
subgenomic mRNAs (a unique hallmark of nidovirus replication for which the Nidovirales order 
is named) to be translated into viral structural proteins (center). Note that the positioning of the 
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viral membrane proteins in the ER should be inverted, such that the ectodomains of the proteins 
should protrude into the ER lumen. Used with permission from de Wit et al. (2016).
Nsp3-DUB.
The nsp3 of MHV contains multiple functional domains with different enzymatic 
properties, including two papain-like protease (PLP) domains that are known to be critical for 
viral replication by cleaving the viral polyprotein into some of its constituent nsps (Ziebuhr et al. 
2000; Mielech, Chen, et al. 2014; Chen et al. 2015; Lei et al. 2018). Other coronaviruses like 
PEDV and HCoV-NL63 also contain two PLPs (PLP1 and PLP2) within their nsp3s, whereas 
SARS-CoV and MERS-CoV only encode a single PLP domain (PLpro) in their respective nsp3 
genes (Mielech, Chen, et al. 2014). In 2005 Sulea et al. published sequence homology data 
revealing that, in addition to its known protease activity, SARS-PLpro exhibited striking 
resemblance to known cellular deubiquitinase (DUB) herpesvirus-associated ubiquitin-specific 
protease (HAUSP, aka USP18). Shortly thereafter, two groups independently demonstrated that 
SARS-PLpro was indeed capable of deubiquitinating K48- and K63-linked polyubiquitin chains 
and showed that this DUB activity was dependent on catalytic residues within the protease 
domain (Barretto et al. 2005; Lindner et al. 2005). Deubiquitinating and deISGylating activities 
have since been reported in PEDV, HCoV-NL63, MERS-CoV, MHV, and other coronaviruses 
(Zheng et al. 2008; Frieman et al. 2009; Clementz et al. 2010; Xing et al. 2013; Mielech, 
Kilianski, et al. 2014). It is well-established that ubiquitination and deubiquitination of many 
proteins are critical post-translational modifications involved in the regulation of multiple innate 
immune pathways, including IFN induction and signaling pathways (Bibeau-Poirier and Servant 
2008; Bhoj and Chen 2009; Fuchs 2012; Heaton et al. 2016). As such, an intriguing possibility is 
that the DUB activity of MHV-PLP2 deubiquitinates host factors in one or more of these 
pathways to disrupt the IFN response during infection.
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That a coronavirus-encoded DUB might disrupt innate immune signaling pathways is not 
without precedent in nature; PLPs from several arteriviruses (which, along with CoVs, 
mesoniviruses, and roniviruses, comprise the Nidovirales order) have also been shown to 
antagonize the IFN response (Frias-Staheli et al. 2007; Sun et al. 2010; van Kasteren et al. 
2012). However, whether or not CoV-encoded DUB activity contributes to suppression and/or 
evasion of antiviral immunity during infection remains unclear. For example, Wang et al. (2011) 
reported that MHV-PLP2 deubiquitinates TBK1, an important kinase involved in IRF3-mediated 
IFN induction, and Xing et al. (2013) demonstrated that PEDV-PLP2 deubiquitinates RIG-I and 
STING, two classic antiviral sensors that induce the expression of type I IFN. These studies 
point to a clear role for CoV-encoded DUBs as IFN antagonists. In contrast, Clementz et al. 
(2010) demonstrated that HCoV-NL63-PLP2 inhibits RIG-I- and TLR3-dependent induction of 
IFN even in the absence of catalytic activity and that SARS-PLpro does not require catalytic 
activity to inhibit IRF3- or NF-B-dependent reporters. Mielech and Kilianski et al. (2014), on 
the other hand, concluded that catalytic activity is required for MERS-PLpro-mediated inhibition 
of a MAVS-induced IFN reporter and a nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-B) reporter and that SARS- and MERS-PLpro both inhibit the expression of other 
pro-inflammatory cytokines. These seemingly contradictory reports could indicate that there 
exist strain-specific differences between coronavirus DUBs; they might also be explained at least 
in part by the distinct experimental procedures used by each group. Nevertheless, this evolving 
body of work strongly suggests that at least some CoV-PLPs antagonize innate immunity and 
implicates DUB activity as a potential IFN antagonist, invoking the need for additional research 
to further investigate this possibility.
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Nsp15-EndoU.
Recent work involving another coronavirus IFN antagonist, nsp15, has shown that it is 
associated with viral replication complexes during infection but, unlike nsp3, is not strictly 
required for the production of virus progeny (Deng et al. 2017; Kindler et al. 2017). Structural 
data and in vitro studies first indicated that nsp15 is an endoribonuclease that forms oligomers 
that recognize and cleave ss- and dsRNA species, with particular affinity for the 3’-ends of 
uridylates (Ivanov et al. 2004; Bhardwaj et al. 2006; Ricagno et al. 2006; Kang et al. 2007). 
Notably, the presence of an endoribonuclease (EndoU) domain is a genetic marker that is 
uniquely conserved among the vertebrate-infecting members of the Nidovirales order (but is 
apparently absent in several recently-characterized arthropod nidoviruses), potentially rendering 
it an excellent target for broad-spectrum rational vaccine design and antiviral therapies (Ivanov 
et al. 2004; Nga et al. 2011; Deng and Baker 2018). However, like nsp3-DUB activity, the role, 
mechanism(s), and specific target(s) of nsp15-EndoU activity during coronavirus infection are 
unclear. Some groups have reported that the preferred target of EndoU is ssRNA, while others 
demonstrated a preference for dsRNA (Bhardwaj et al. 2004; Ivanov et al. 2004). Recently, we 
and others showed that MHV-EndoU co-localizes with dsRNA within replication complexes and 
that infection with a mutant MHV strain encoding a catalytically-inactive EndoU resulted in 
increased accumulation of cytosolic dsRNA, collectively implicating dsRNAs—obligate 
intermediates in the replication of positive-sense RNA viruses—as the primary targets of EndoU 
(Deng et al. 2017; Kindler et al. 2017). These studies also provided compelling data to suggest 
that at least one role for EndoU activity during infection is to suppress the type I IFN response 
and limit apoptosis in macrophages in a manner that involves evasion and/or antagonism of host 
sensing by RIG-I, MDA-5, and the PKR and OAS/RNase L systems (Deng et al. 2017; Kindler 
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et al. 2017). Thus, nsp15-EndoU is one of the newest additions to the ever-growing list of CoV-
encoded IFN antagonists. 
IFN Antagonists Are Compelling Targets for Rational Vaccine Design
Due to its critical roles in initiating and mediating the innate antiviral response and even 
priming adaptive antiviral immunity, IFN induction and signaling must be antagonized and/or 
evaded by viruses in order for them to replicate and spread efficiently, a requirement that has led 
to the evolution of numerous strategies for IFN suppression in most viruses (Figure 5) (Haller et 
al. 2006; Schoggins and Rice 2011; Ivashkiv and Donlin 2014; Schulz and Mossman 2016). 
Because of this relationship between host immunity and viral antagonism, virus-encoded IFN 
antagonists like nsp3-DUB and nsp15-EndoU are appealing targets for the rational design of 
CoV vaccine strains. In addition to their roles as IFN antagonists, nsp3-DUB and nsp15-EndoU 
activities are ideal candidates for targeted vaccine design because they are conserved among 
most known nidoviruses, including the highly pathogenic SARS- and MERS-CoVs (Ivanov et al. 
2004; Mielech, Chen, et al. 2014). A universal approach to generating live-attenuated versions of 
current and future CoVs might therefore be achieved by specifically disrupting conserved viral 
proteins like nsp3-DUB and nsp15-EndoU, thereby allowing for the rapid development of 
vaccines to protect against novel emergent strains. Conceptually, if the ability of a virus to evade 
and/or suppress the antiviral response can be disrupted without abrogating virus replication in 
vitro—an important requirement for vaccine production—perhaps such a live-attenuated virus 
will elicit a sufficient and appropriate immune response that will restrict its replication in vivo 
without causing disease and spur the induction of immunological memory that is protective 
against infection by the wild type strain. Notably, the logic of this strategy is supported by the 
results of the study shown in Figure 6, which suggested that manipulating the IFN response such 
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that IFN signaling occurs earlier during SARS-CoV infection might be sufficient to attenuate the 
virus without causing clinical disease (Channappanavar et al. 2016). The possibility of 
generating live-attenuated virus strains by deleting or disrupting virus-encoded IFN antagonists 
is currently being studied for a number of viruses, including MHV, MERS-CoV, SARS-CoV, 
Nipah virus, measles virus, Sindbis virus, West Nile virus, respiratory syncytial virus, and 
influenza A virus (Talon et al. 2000; Laurent-Rolle et al. 2010; Simmons et al. 2010; Yoneda et 
al. 2010; Devaux et al. 2011; Teng 2012; Deng et al. 2017; Menachery, Gralinski, et al. 2017; 
Du et al. 2018; Menachery et al. 2018). Indeed, recent studies involving IFN antagonist-deficient 
strains of influenza A virus are in the proof-of-concept stage and have shown remarkable 
promise in the lab, demonstrating the potential for IFN antagonist-deficient viruses as live-
attenuated vaccines in vivo (Du et al. 2018).
EndoU-mut- and DUB-mut-MHV Vaccine Candidates.
Using a mutant strain of MHV that encodes a histidine to alanine substitution (H262A) in 
the catalytic triad of nsp15-EndoU, illustrated in Figure 7, we recently demonstrated the utility of 
EndoU activity as a target for vaccine design. The replication of EndoU-mut-MHV was 
profoundly attenuated in vitro in normal murine BMDMs but exhibited WT-like replication 
kinetics in macrophages that were deficient in type I IFN signaling; accordingly, we also found 
that this strain elicited robust expression of type I IFN during infection of wild type macrophages 
(Deng et al. 2017). Furthermore, EndoU-mut-MHV was strikingly attenuated in vivo (Figure 9) 
and inoculated mice were protected from disease upon subsequent challenge with the parental 
strain (Deng et al. 2017). In unpublished data from a manuscript in preparation, we also found 
that a different mutant strain of MHV encoding an aspartate to alanine substitution (D250A, 
Figure 7) that impairs the DUB—but not the protease—activity of MHV-PLP2 also induced 
earlier and more robust expression of type I IFN than the parental strain. We were surprised, 
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therefore, when subsequent in vivo studies using this DUB-mutant-MHV reproducibly resulted in 
no statistically significant difference in mortality or clinical pathology in mice compared with 
infection using the WT parental strain (Deng et al. manuscript in preparation) (Figure 9). That 
two distinct MHV mutants, each encoding a different catalytic mutation in a different IFN 
antagonist, both amplified IFN expression during infection but were associated with dramatically 
different responses in vivo suggests that the mere induction of type I IFN during infection is not a 
sufficient marker for an effective live-attenuated coronavirus vaccine strain. Additionally, these 
data preliminarily indicate that nsp15 is capable of dysregulating the host response to a greater 
extent than nsp3, suggesting that CoVs encode a hierarchy of IFN antagonists that work in 
concert to modulate antiviral immunity at multiple steps. In the work described herein, we sought 
to determine how a host cell responds differently to EndoU-mut- and DUB-mut-MHV infections 
at the level of transcription in order to better understand the dynamics that might explain the 
distinct outcomes of infection with these mutant strains that we observed in vivo.
Figure 9. Infection with DUB-mut- or EndoU-mut-MHV Leads to Distinct Responses in 
Mice. (Left) Mice inoculated intracranially with 600 pfu of DUB-mut- or WT-MHV all 
succumbed to infection by 9 days-post infection. Used with permission from Deng et al., 
manuscript in preparation. (Right) Mice inoculated intracranially with 600 pfu of EndoU-mut-
MHV all survived infection compared with WT-MHV-infected mice. Modified with permission 
from Deng et al. (2017). (Both panels) Mouse numbers for each group are indicated in 
parentheses. Data are representative of at least two independent experiments.
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Utilizing RNA-sequencing to Study CoV-infected Cells and Tissues
To investigate the factors that might contribute to the differential outcomes of in vivo 
infection with EndoU-mut- and DUB-mut-MHV (Figure 9), we applied RNA-sequencing (RNA-
seq) to primary murine bone marrow-derived macrophages (BMDMs) infected with EndoU- 
mut-, DUB-mut, or WT-MHV to obtain a profile of the transcriptional responses elicited by each 
virus. Other groups have sequenced the transcriptomes of non-immune CoV-infected cell types 
infected using microarrays or RNA-seq, obtaining results that collectively suggest that the cell 
type and identity of the infecting virus largely dictate the transcriptional response to coronavirus 
infections. Table 1 outlines the major findings from a number of these published studies in 
various cell and tissue types. Given that the 6 known human CoVs most commonly cause 
respiratory disease in their hosts, RNA-seq or microarray experiments involving coronaviruses 
are most commonly performed in cells derived from lung and airway tissues such as Calu-3 cells, 
A549 cells, LA-4 cells, HAE cells, lung tissue homogenates, trachea tissue homogenates, among 
others (see Table 1 for references). Another common cell type used in transcriptomic studies of 
CoV infections is the fibroblast (17Cl-1 cells, MEFs, L cells, etc.) (Table 1). Notably, in 2005 
Cheung et al. published the only paper of which we are aware in which full transcriptome 
sequencing (using microarray technology) was applied to CoV-infected macrophages (see Table 
1); however, this publication only contains the microarray data for 35 genes at a single, early 
timepoint (3 hpi). The authors revealed that, although SARS-CoV did not induce the expression 
of any type I IFN gene by 3 hpi, the infected macrophages expressed appreciable amounts of 
several chemokines that are known to be important in the context of inflammatory disease, 
thereby implicating macrophage activity in SARS-CoV pathogenesis. Despite the important 
contributions that these studies have made toward our understanding of CoV-induced 
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transcriptional changes, the striking lack of transcriptomic data from CoV-infected primary 
macrophages over multiple timepoints renders a large gap in what is known about how the innate 
immune system responds to these infections. What are the consequences of coronavirus-
mediated IFN antagonism in the very cells that represent a first line of cellular defense against 
the viral infection?
Cell or Tissue 
Type(s) Coronavirus(es) Major Finding(s) Reference
17Cl-1 (mouse 
fibroblast) cells
MHV-A59 MHV induced an unfolded protein response (UPR) and host 
translation shutoff within the first 8 hours post-infection (hpi).
Irigoyen et al., 
preprint (2018)
mouse lung tissue 
homogenates
SARS-CoV WT-SARS-CoV and a mutant SARS-CoV lacking its nsp16 
(Δnsp16) induced similar global transcriptional responses thru 2 
dpi. By 6 dpi, the host response to Δnsp16-SARS-CoV was 
markedly diminished relative to the WT parental strain.
Menachery et al., J 
Virol (2018)





Virulent IBV upregulated the expression of apoptosis genes and 
downregulated the expression of innate immune response and 
cellular metabolism genes by 5 and 6 dpi.
Liu et al., Microb 
Pathog (2017)
Calu-3 (human lung 
epithelium) cells; 
human airway 
epithelial (HAE) cells 
MERS-CoV MERS-CoV lacking ORFs 3-5 dysregulated host responses by 24 
hpi, marked by the induction of IFN and robust inflammation.
Menachery et al., 
mBio (2017)
Calu-3 cells MERS-CoV; 
SARS-CoV
The absence of SARS- and MERS-CoV-encoded 2’-O-
methyltransferase (2’O-MTase) activity during infection yielded 
significant transcriptional changes thru 24 and 72 hpi, 
respectively, relative to WT infections.








HCoV-229E HCoV-229E fine-tuned NF-κB signaling, inducing NF-κB-
dependent and independent gene expression, and reprogrammed 
the host’s chromatin landscape thru 2 dpi.
Poppe et al., PLOS 
Pathog (2017)
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Cell or Tissue 
Type(s) Coronavirus(es) Major Finding(s) Reference
LA-4 (murine lung 
epithelium) cells
MHV-1 MHV infection had a limited impact overall on the host 
transcriptome and only minimally upregulated the expression of 
IFNs and ISGs by 24 hpi.
VanLeuven et al., 
PLOS ONE (2017)
mouse lung tissue 
homogenates
SARS-CoV By 9 dpi, several genes associated with wound healing and 
fibrosis were differentially expressed in the lungs of STAT1-/- 
mice and mice in which EGFR (epidermal growth factor receptor) 
is constitutively active.
Venkataraman et 
al., J Virol (2017)
mouse lung tissue 
homogenates
MERS-CoV MERS-CoV profoundly perturbed the expression of thousands of 
host genes by 7 dpi, impacting the immune response in a way that 
implicated T cell and macrophage recruitment during infection.
Coleman et al., J 
Virol (2017)
17Cl-1 cells MHV-A59 RNA-seq allowed for detailed profiling of the replication and 
translation kinetics of the MHV genome during the first 8 hpi.
Irigoyen et al.,  
PLOS Pathog 
(2016)
mouse lung tissue 
homogenates
SARS-CoV A number of immune response genes were differentially 
expressed upon SARS-CoV infection; the effects of Kepi and 
TNF expression were found to be of particular importance and 
were shown to oppositely impact pathogenesis.
McDermott et al., 
BMC Syst Biol 
(2016)
swine testis (ST) cells TGEV > 50 microRNAs, a number of which are immune-related, were 
found to be differentially expressed during infection.
Liu et al., PLOS 
ONE (2015)
marmoset lung tissue 
homogenates
MERS-CoV Pathways associated with chemotaxis, cell proliferation, 
fibrogenesis, inflammation, vascularization, endothelial 
activation, tissue repair, and others were upregulated thru 3-6 dpi 
in individual animals. No expression of type I IFN was observed.




Cell or Tissue 
Type(s) Coronavirus(es) Major Finding(s) Reference
mouse embryonic 
fibroblast (MEF) cells; 
mouse lung tissue 
homogenates
SARS-CoV Significant differential expression of > 5,000 lncRNAs occurred 
by 4 dpi upon infection of multiple strains of mice.
Josset et al., RNA 
Biol (2014)
Calu-3 cells MERS-CoV; 
SARS-CoV
Both MERS- and SARS-CoV delayed type I IFN and subsequent 
ISG responses.
Menachery et al., 
mBio (2014)
mouse lung tissue 
homogenates
SARS-CoV Thousands of novel transcripts were induced during SARS-CoV 
infection by 2 dpi; the induction of most of these transcripts was 
markedly diminished by 4 dpi.
Xiong et al., G3 
(Bethesda) (2014)
chicken kidney tissue 
homogenates
IBV Upon analysis 5 or 6 dpi, tissues exhibited significant differential 
expression of genes in multiple pathways. Regulation of > 100 
genes associated with inflammation was found to be particularly 
important during the response to infection.
Cong et al., BMC 
Genomics (2013)
ST cells TGEV TGEV lacking its gene 7 upregulated host genes involved in the 
immune response, the interferon response, and inflammation by 
12 hpi.
Cruz et al., J Virol 
(2013)
mouse spinal cord 
tissue homogenates
MHV-A59 Expression of several genes involved in osteoclast or bone-
resident macrophage function, as well as genes characterizing a 
Th1-biased cytokine/chemokine response, accompanied persistent 
MHV infection by 33 dpi.
Elliott et al., PLOS 
ONE (2013)
Crandell Rees feline 
kidney (CRFK) cells
FIPV FIPV infection significantly upregulated a handful of genes by 3 
hpi, the majority of which were associated with macrophage and 
Th1 cell functions and the regulation of apoptosis.
Harun et al., Virol 
J (2013)
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Cell or Tissue 
Type(s) Coronavirus(es) Major Finding(s) Reference
Calu-3 cells MERS-CoV; 
SARS-CoV
MERS- and SARS-CoVs induced both overlapping and distinct 
transcriptional responses, especially after 12 hpi.
Josset et al. mBio 
(2013)
ferret lung tissue 
homogenates
SARS-CoV Initial infection with SARS-CoV upregulated the expression of 
genes in innate immune and IFN signaling pathways thru 14 dpi 
and genes involved in adaptive immunity by 28 dpi. Reinfection 
did not stimulate IFN-responsive gene expression.







SARS-CoV SARS-CoV without its E protein upregulated the expression of a 
handful of genes, most of which are involved in the stress 
response, compared with WT-SARS-CoV infection thru 15 and 
65 hpi, depending on the cell type.
DeDiego et al., 
PLOS Pathog 
(2011)
mouse lung tissue 
homogenates
SARS-CoV SARS-CoV induced differential expression of more than 200 
small RNAs by 2 dpi, revealing a role for non-protein-coding 
transcripts in coronavirus infections.
Peng et al., mBio 
(2011)
L cells (fibroblast-like) MHV-A59 Very few transcriptional changes occurred by 3 hpi; by 6 hpi a 
chemokine response was induced along with changes in RNA and 
protein metabolism, the cell cycle, and apoptosis. IFN was not 
triggered during infection.
Versteeg et al., J 
Gen Virol (2006)
chicken trachea tissue 
homogenates
IBV Innate immune and Th1-biased adaptive immune responses were 
induced by 3 dpi in response to IBV infection.




SARS-CoV By 3 hpi, SARS-CoV-infected macrophages expressed no 
detectable type I IFN but did express several chemokines.
Cheung et al., J 
Virol (2005)
Table 1. Summary of Transcriptional Profiling Studies Involving Coronavirus-infected Cells and Tissues. Entries are 
arranged first by date of publication and second, when necessary, by first author’s last name. 40
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The Importance of Macrophages in CoV Infections.
For this project, we elected to utilize primary BMDMs, which are known to produce a 
substantial portion of secreted type I IFN during infection and are also potently IFN-responsive, 
relying on IFN signaling to dictate the induction and execution of an antiviral response (Ivashkiv 
and Donlin 2014). Given that the goal of this work was to investigate a host cell’s transcriptional 
response to IFN antagonist-deficient mutant CoVs, it was important that we use an IFN-
responsive cell type. Additionally, many CoVs—including MHV, SARS-CoV, MERS-CoV, 
HCoV-229E, IBV, FIPV, among others—have been shown to naturally and productively infect 
macrophages (Bang and Warwick 1960; Virelizier and Allison 1976; Collins 2002; Yilla et al. 
2005; Zhou et al. 2014; Amarasinghe et al. 2017; Shirato et al. 2018). The IFN-responsiveness 
of macrophages (via signaling through the type I IFN-α receptor) has even been shown to be 
critical for controlling MHV infection, implicating macrophages and type I IFN signaling as key 
players in the anti-coronaviral immune response (Cervantes-Barragán et al. 2009). Likewise, 
depletion of macrophages has been shown to exacerbate MERS-CoV pathology in mice 
expressing the human MERS-CoV receptor (Coleman et al. 2017). On the other hand, 
Channappanavar et al. (2016) demonstrated that at least one type of macrophages—termed 
inflammatory monocyte-macrophages (IMMs)—accumulated during SARS-CoV infection and 
contributed to the development and worsening of severe disease. In a similar vein, Hartwig et al. 
(2014) showed that depletion of alveolar macrophages reduced MHV-induced morbidity and 
mortality in intranasally-infected mice. The work of Zhou et al. (2014) proposed that secretion of 
pro-inflammatory cytokines by macrophages exacerbates the development of severe pneumonia 
and respiratory dysfunction in patients infected with MERS-CoV. Taken together, the results of 
these studies indicate that IFN-responsive macrophages play a central role in the host’s response 
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to CoV infections and that dysregulated accumulation and/or transcriptional responses of certain 
types of macrophages may even contribute to the severity of coronavirus-induced disease.
A recent paper by Savarin et al. (2018) described the expression profiles of 754 genes in 
mouse BMDMs in response to an in vivo infection with a neurotropic strain of MHV (strain 
JHM) between 5-14 dpi using a gene expression panel technology called “nCounter.” Although 
the method of expression profiling used by the authors did not involve global transcriptomic 
profiling, to our knowledge this is nevertheless the only published report that contains extensive 
gene expression profiling data from coronavirus-infected macrophages. The results of this study, 
which most notably revealed a mix of upregulated M1- and M2-associated gene expression in 
MHV-infected BMDMs, provide a partial view of a macrophage’s transcriptional response to 
coronavirus infection. The authors concluded, in agreement with previous reports, that BMDMs 
likely do not play an essential role in the overall pathogenesis of MHV-JHM in their murine 
model of multiple sclerosis-like demyelination (Savarin et al. 2018). However, we speculate that 
the lack of data prior to 5 dpi leaves open the possibility of BMDM involvement in the early 
innate immune response to infection. Additionally, since gene expression was assessed in 
BMDMs that were isolated from the spinal milieu of infected mice, it is unclear whether or not 
the BMDMs were themselves infected by the virus. In order to investigate the full scope of the 
transcriptional response to CoV infection in macrophages, we determined that the use of 
microarray or RNA-seq technology is required. Using RNA-seq, we therefore sought to explore 
the dynamics of the transcriptional response that occurs in BMDMs upon MHV infection in the 
presence and absence of MHV-encoded IFN antagonists. The results of our work point to 
profound transcriptional dysregulation of nearly 2,900 host genes during MHV infection of 
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murine BMDMs, including a staggering majority of which that were differentially regulated by 





EndoU-mut- and DUB-mut-MHV strains were derived from parental WT-MHV A59 
strain (GenBank accession # AY910861) (Figure 7), all of which were generated by Dr. Xufang 
Deng, Loyola University Chicago, Maywood IL, by process of reverse genetics as described by 
Yount et al. (2002). All viruses were subjected to whole-genome sequencing to confirm the 
results of reverse genetics.
Generation and Culture of Murine Bone Marrow-derived Macrophages
Extraction of Bone Marrow from Mice.
To obtain BMDMs, total bone marrow was first extracted from the femurs of C57BL/6J 
mice (#000664, The Jackson Laboratory). Mice were euthanized by use of CO2, their femurs 
removed, and the contents of the femoral marrow cavities were flushed out using Dulbecco’s 
Modified Eagle’s Medium (DMEM, #10-017-CV, Corning). The mixture of bone marrow + 
DMEM was centrifuged at 500 rpm for 1 min at 4 ºC, the supernatant transferred to a new tube 
and centrifuged again at 1500 rpm for 5 min at 4 ºC. The cell pellet from the second 
centrifugation was resuspended in 10 mL of DMEM, cells were counted, and 5 x 106 cells were 
plated in 15 mL of “bone marrow/macrophage medium” (BMM) medium supplemented with 
0.1% 5 x 10-2M β-mercaptoethanol (βME) in 100 x 26 mm Petri dishes (25387-030, VWR).
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Bone Marrow/Macrophage Medium.
The recipe for BMM medium is as follows: DMEM supplemented with 30% L929 cell 
supernatant (obtained as described below); 20% fetal bovine serum (FBS); 1% 0.2M L-
glutamine; and 1% 0.1M sodium pyruvate. When differentiating bone marrow into BMDMs, 
BMM medium was also supplemented with 0.1% 5 x 10-2M (βME).
L929 Cell Medium and Conditioned Supernatant.
L929 cells, which secrete macrophage colony-stimulating factor (M-CSF), were a gift 
from Dr. Francis Alonzo, Loyola University Chicago, Maywood IL. To generate L929 cell 
conditioned supernatant for use in BMM medium as described above, L929 cells were cultured 
in the following medium: DMEM supplemented with 10% FBS; 1% 0.2M L-glutamine; 1% 
0.1M sodium pyruvate; 1% nonessential amino acids; 1% penicillin/streptomycin. Specifically, 
3.75 x 105 cells were plated in 75 mL L292 medium in a T150 flask (#10-126-34, Thermo 
Fisher) and incubated for 6 d at 37 ºC and 5% CO2, after which point the supernatant was 
collected, filtered, and frozen in 50 mL aliquots at -20 ºC for later use in making BMM medium.
Differentiating Bone Marrow into Macrophages.
Upon plating bone marrow in BMM medium supplemented with 0.1% 5 x 10-2M βME, 
cells were incubated at 37 ºC and 5% CO2. After 72 hr, 10 mL fresh BMM medium (without 
βME) was added to each plate and cells were incubated for an additional 72 hr, after which point 
the bone marrow cells had differentiated into macrophages (BMDMs). Media was removed from 
plates and cells—now macrophages—were washed with 1x cold PBS, after which point an 
additional 1x PBS was added to each plate and cells were incubated at 4 ºC for 30 min. This 
refrigerated incubation aided in gently detaching macrophages from the plates. After 30 min, 
macrophages were washed off the plates by repeatedly and gently pipetting the cold PBS over 
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the cell monolayer. The resultant PBS + macrophage mixture was centrifuged for 5 min at 1500 
rpm, the supernatant removed, and cells resuspended in BMM medium (without βME) for use in 
experiments as described below. Alternatively, 1 x 107 cells/mL were suspended in BMM 
medium with 10% DMSO and stored in liquid nitrogen until later use.
Infection of BMDMs
BMDMs were obtained as described above and 24 hr prior to infection, 6 x 105 BMDMs 
were plated in 1 mL BMM medium per well in a 12-well plate. Alternatively, frozen BMDMs 
were first reconstituted by incubation in 100 x 26 mm Petri dishes in BMM media for 3 days at 
37 °C and 5% CO2. After 3 days, 6 x 105 BMDMs were plated onto 12-well plates and grown for 
24 hr before use in infection experiments. After 24 hr, media was removed from the wells and 
cells were washed once with PBS. 400 µL infectious media (comprising EndoU-mut-, DUB-
mut-, or WT-MHV virus at MOI = 1.0, aka 6 x 105 pfu per well, in fresh DMEM) was added to 
BMDMs; alternatively, for mock-infected controls, 400 µL fresh DMEM was added in lieu of 
inoculum. Wells were infected in quadruplicate for each infection condition in each timepoint 
(e.g., a total of 16 wells were incubated with infectious medium containing 6 x 105 pfu EndoU-
mut-MHV, 4 of which were infected for a total of 3 hr, another 4 of which were infected for a 
total of 6 hr, etc.). After 1 hr of incubation—tilting the plates every 15 min to ensure even 
coverage—inocula were removed and 1 mL fresh BMM medium without βME was added to 
each well. EndoU-mut-, DUB-mut, and WT-MHV-infected cells were then cultured for an 
additional 2, 5, 8, or 11 hr (for 3, 6, 9, and 12 hr total, respectively), whereas mock-infected cells 
were only cultured for 3 hr total. After these timepoints, media was removed from wells and 350 
µL RLT buffer (79216, Qiagen) was added. BMDMs were scraped off the bottom of the wells 
and the RLT + BMDM lysate mixtures were frozen at -80 ºC until subsequent RNA isolation.
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RNA Isolation, cDNA Synthesis, and qRT-PCR
RNA isolation.
Total RNA was isolated from all RLT + BMDM lysate samples—obtained from virus- 
and mock-infected cells as described above—using an RNeasy Mini Kit (74104, Qiagen) per the 
manufacturer’s instructions. The concentration of isolated RNA per sample was determined 
using NanoDrop technology. An average of 6,950 ng of total RNA was isolated from each well.
cDNA Synthesis.
To determine the expression of Ifna11, 18S rRNA, and MHV N gene, an equal amount of 
total isolated RNA (733 ng) was used as the template for cDNA synthesis using an RT2 HT First 
Strand Kit (330401, Qiagen) per the manufacturer’s instructions.
qRT-PCR.
Upon obtaining cDNA for all samples in this manner, qRT-PCR was performed using 
specific primers for murine Ifna11 (PPM03050B-200, Qiagen), murine 18S rRNA (PPM57735E, 
Qiagen), and MHV N gene (FWD: 
5’-AGCAGACTGCAACTACTCAACCCAACTC-3’; REV: 
5’-GCAATAGGCACTCCTTGTCCTTCTGCA-3’). RT2 SYBR Green qPCR Mastermix 
(330502, Qiagen) was used per the manufacturer’s instructions in the Bio-Rad CFX96 
thermocycler system, in which the qRT-PCR experiments were set up as follows: one step at 95 
ºC for 10 min; 40 cycles of 95 ºC for 15 sec each followed by 60 ºC for 1 min and subsequent 
plate read; one step at 95 ºC for 10 sec; and a melt curve step obtained from 65 to 95 ºC at 
increments of 0.5 ºC/5 sec. All samples were evaluated in this manner in technical triplicate and 
the data shown in Figures 11 and 12 are representative of at least 3 independent experiments. 
The levels of mRNA of the genes of interest (Ifna11 and N gene) were normalized to the 
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expression of 18S rRNA and reported as fold-change relative to mock- or WT-MHV-infected 
cells, respectively. Fold induction values were calculated using the 2-∆∆Ct method with the 
following formula: 2-∆∆Ct [∆Ct = (Ct(gene of interest) − Ct(18s rRNA)) ; ∆∆Ct = (∆Ct(test sample) – 
∆Ct(calibrator group))].
RNA-seq and Subsequent Data Processing, Visualization, and Analysis
RNA-seq.
At least 12 µL of total RNA at a concentration of at least 100 ng/µL—isolated from 
EndoU-mut, DUB-mut, WT-MHV-, and mock-infected BMDMs as described above—was 
submitted to the University of Chicago Genomics Facility (UCGF) for RNA-sequencing. 
Although BMDMs were initially infected in quadruplicate, only 3 replicate samples from each 
infection group in each timepoint were submitted for sequencing, for a total of 39 samples (3 
mock-infected samples at 3 hpi; 3 EndoU-mut-MHV-infected samples at 3, 6, 9, and 12 hpi; 3 
DUB-mut-MHV-infected samples at 3, 6, 9, and 12 hpi; and 3 WT-MHV-infected samples at 3, 
6, 9, and 12 hpi). Prior to initiating library preparation, the UCGF first applied quality control 
analyses to all RNA samples, the results of which are shown in Table 2 in the Results chapter of 
this document. After passing quality control, samples were subjected to poly-A selection (to 
enrich mRNAs) and subsequent single-read, 50 bp (SR50) sequencing using Illumina HiSeq 
4000 technology. Per our request that an approximately equal number of total reads (~4.0 x 106) 
be generated per sample, approximately 1.6 x 109 total reads were obtained in this manner across 
all samples. Raw (unprocessed) reads were downloaded in the form of 7 FASTQ files per sample 
and were subjected to analysis and processing as described below.
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Processing and Analysis of RNA-seq Data Using Galaxy.
We utilized the public server of an online bioinformatic data manipulation platform 
called Galaxy (https://usegalaxy.org/) to process and analyze the raw reads obtained from the 
UCGF in order to derive differential gene expression information from the raw data (Afgan et al. 
2016). The process by which we analyzed the raw reads using Galaxy is outlined schematically 
in Figure 13 in the Results chapter. Raw reads (in the form of FASTQ files) were uploaded 
directly to Galaxy. The sequence and annotation files of the GRCm38 Ensembl build of the 
C57BL/6J mouse genome were downloaded from Illumina’s iGenomes website 
(https://support.illumina.com/sequencing/ sequencing_software/igenome.html). These files were 
too large to be uploaded directly to Galaxy and were instead uploaded by way of FileZilla, which 
is a free FTP client that is readily downloadable from the internet (https://filezilla-project.org/). 
Once all files were successfully uploaded into Galaxy, we first clipped all FASTQ files to 
remove any residual unique barcode sequences (the vast majority of which had been removed 
already by the UCGF prior to making the raw read data available to us) using the “Clip adapter 
sequences” (Galaxy version 1.0.2) tool. The default options were kept, with the exception of the 
following: “discard sequences with unknown (N) bases” was changed to “no;” and “output 
options” was changed to “output both clipped and non-clipped sequences” to ensure that reads 
that had already been clipped by the UCGF were not eliminated from the outputs. Once clipped, 
FASTQ files were then concatenated (combined) such that a single FASTQ file pertained to each 
sample. This was achieved using the “Concatenate datasets tail-to-head (cat)” (Galaxy version 
0.1.0) tool. There were no changeable parameters associated with this tool. Next, concatenated 
files were “groomed” using the “FASTQ Groomer” (Galaxy version 1.1.1) tool to ensure that all 
reads were in the appropriate Sanger FASTQ format (all files and reads should have already been 
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in FASTQ format upon receipt from the UCGF, such that this step was merely an opportunity for 
us to double-check the format of the data that we had downloaded from the UCGF). No defaults 
were changed at this step. After grooming, all files were appropriately clipped, combined, and in 
the required FASTQ format.
We next sought to align the reads in all samples to the mouse genome. Notably, all virus-
infected samples were expected to contain reads that originated from mouse RNA and reads that 
originated from viral RNA, since both species of RNA would have been present in the original 
samples that we submitted for sequencing. As such, we performed two alignment steps, the first 
of which was intended to weed out any non-murine (i.e., viral) reads in order to reduce file sizes 
since the public domain of Galaxy only allows for a relatively small amount of data storage at 
one time. Thus, we first aligned all reads to the mouse genome using the “HISAT2” (Galaxy 
version 2.1.0) alignment tool (Kim et al. 2015). Instead of using a built-in genome, we used the 
version of the C57BL/6J sequence that we previously uploaded into Galaxy. Other default 
options were left unchanged with the following exception: under “Advanced Options > Output 
options” the option to “write aligned reads (in fastq format) to separate file(s)” was changed to 
“yes” since we wanted to keep only those reads that corresponded to the murine genome. After 
obtaining aligned (i.e., murine-only) reads as an output from this first alignment step in the form 
of a FASTQ file, those reads were again submitted to HISAT2 to obtain the alignment 
information in the form of a single BAM file for each sample. For this second alignment step, 
default options were left unchanged except that we again used the C57BL/6J sequence as a 
reference genome instead of a built-in genome.
After removing non-murine reads from all samples and aligning the remaining murine-
only reads to the mouse genome, we next counted the number of reads that pertained to each 
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annotated gene in the genome using the “featureCounts” (Galaxy version 1.6.0.6) tool (Liao et 
al. 2014). Using as inputs into featureCounts the BAM files that were generated as a result of the 
second HISAT2 alignment step, we did not change any default options except for the following: 
“gene annotation file” was changed to “in your history” in order to utilize the annotation file for 
the C57BL/6J genome that we previously uploaded into Galaxy. After applying featureCounts in 
this manner to the single BAM file associated with each sample, the final step we employed was 
to determine differential gene expression using “DESeq2” (Galaxy version 2.11.40.2) (Love et 
al. 2014). Using as inputs into DESeq2 the tabular outputs that were generated as a result of the 
featureCounts step, we ran DESeq2 separately for each timepoint (3, 6, 9, and 12 hpi). We 
specified the factor name as “Virus_Infection” and 4 factor levels for each timepoint as “Mock,” 
“WT,” “EndoU-mut,” and “DUB-mut” and uploaded the appropriate tabular files from 
featureCounts into each factor level (i.e., the tabular files associated with EndoU-mut-MHV-
infected BMDMs—in triplicate—were uploaded into the respective timepoint, and so on). Note 
that the same 3 tabular files associated with mock-infected cells at 3 hpi (in triplicate) were used 
in the DESeq2 analysis of all 4 timepoints. The following options were changed from their 
defaults: “output normalized counts table” was changed to “yes;” and “output all levels vs all 
levels of primary factor” was changed to “yes.” Using these parameters, DESeq2 generated as 
outputs 7 total files for each timepoint: 6 tabular files containing the differential expression 
analyses for each gene in the mouse genome each containing a different comparison (Mock vs 
WT, Mock vs DUB-mut, Mock vs EndoU-mut, DUB-mut vs WT, EndoU-mut vs WT, and DUB-
mut vs EndoU-mut) and a 7th tabular file containing the normalized count information for all 
genes across all replicate samples. Importantly, these DESeq2-generated “normalized” counts are 
distinct from the “raw” counts from which they were derived. In order to account for differences 
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in sequencing depths between libraries (aka samples), DESeq2 automatically normalizes raw 
count data to scale up or down those counts for each gene according to the number of total 
counts in each sample relative to the others. This process of normalization is described in depth 
by Love et al. (2014). The normalization of raw reads was particularly important for our datasets 
since our mock-infected samples contained a substantially larger number of total murine reads 
than did virus-infected samples (especially as the infection developed over time, as transcription 
of the viral genome begins to overwhelm expression of host genes as infection progresses). 
These normalized counts are then used by DESeq2 to calculate differential expression in the 
form of fold-change; we also used these normalized count values to generate Figures 14, 16-19, 
and 21 in the Results and Discussion chapters of this document.
Method for Independent Confirmation of DESeq2-generated Normalized Counts.
We sought to independently confirm that the process by which DESeq2 produces 
normalized reads from raw counts did not inappropriately skew our data. Therefore, in addition 
to creating Figures 14 and 16-19 using the DESeq2-generated normalized counts for each 
timepoint, we utilized the raw count data (which was produced as the output of the featureCounts 
tool) to generate similar heatmaps and line graphs. If the normalized counts were appropriately 
derived from the raw counts without skewing the data, then the general patterns displayed in a 
heatmap produced using normalized counts should be visually similar to one produced using the 
values obtained by dividing the number of raw counts for each gene by the total number of raw 
reads in each sample. The same should also be true of line graphs constructed using the two 
different kinds of count data. Indeed, as shown in Figure 10 below, that is what we found. Figure 
10A shows two heatmaps containing the gene expression data for only the 12 hpi timepoint 
(using the same gene list as in Figure 14 in the Results chapter of this document) in the form of 
53
either row z-score-standardized normalized counts or row z-score-standardized raw counts. 
Notably, the colors (and therefore the row z-scores) are often not the same for each gene between 
the two heatmaps, which is not unexpected given that the actual values of the normalized and 
raw gene counts divided by the total raw counts are not the same; however, the overall patterns 
of differential gene expression are conserved between the two heatmaps. Similarly, Figure 10B 
displays line graphs for 3 different genes—Ifna11, Ifih1, and Csf1—using either raw reads for 
each gene divided by the total number of raw reads in each sample or DESeq2-generated 
normalized reads. These line graphs, like the heatmaps, demonstrate that the overall patterns of 
gene expression observed between samples over time were conserved regardless of which type 
of count data is used. Thus, having confirmed the validity of the DESeq2-generated normalized 
counts by an independent means of data analysis and presentation, we were confident that the 
normalized count data were appropriate for use in our analyses shown in multiple figures and 
tables in the Results chapter.
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Figure 10. Method for Independent Confirmation of DESeq2-generated Normalized 
Counts. (A) Heatmaps showing gene expression data for the same 2,879 genes as in Figure 14 at 
12 hpi only. On the left, DESeq2-generated normalized counts were plotted as row z-scores; on 
the right, raw counts for each gene were divided by the total number of raw counts in each 
sample and the resulting values were plotted as row z-scores. Color keys indicate the colors that 
correspond to each z-score value, with warmer colors indicating higher relative expression in 
each row and cooler colors corresponding to lower relative expression. (B) Line graphs showing 
gene expression data as non-z-score-standardized counts over time for 3 genes. The graphs in the 
top row were produced by plotting the values that were obtained by dividing the raw read counts 
for each gene by the total number of raw reads in each sample (as determined from data analysis 
using featureCounts). The graphs in the bottom row display DESeq2-generated normalized 
counts for the same 3 genes. Data are presented as means ± SD.
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Selecting the Most Highly Differentially-expressed Genes.
After obtaining differential expression data for all genes across all samples and 
timepoints using Galaxy, we next generated a list of the most highly upregulated genes that we 
would use in subsequent analyses. To do this, we analyzed the differential expression data—
generated as an output of DESeq2 analysis—between WT-MHV-infected BMDMs at 12 hpi and 
mock-infected cells and selected only those genes whose differential upregulation in WT-MHV-
infected cells (as determined by DESeq2) was statistically significant by eliminating genes 
associated with a q-value (adjusted p-value, calculated by DESeq2 using the Benjamini-
Hochberg procedure) of > 0.05 (Love et al. 2014). We applied an additional parameter using a 
fold-change magnitude cutoff, such that genes that were not differentially upregulated by at least 
4-fold (aka a log2 fold-change value > 2) in WT-MHV-infected- compared with mock-infected 
BMDMs were excluded. After applying these cutoffs, 2,879 genes remained.
Visualizing Gene Expression Data.
Upon identifying the top 2,879 genes that were most differentially expressed between 
WT-MHV-infected- and mock-infected BMDMs, we next sought to visualize the expression data 
for these genes in heatmap form. To do this, we averaged the normalized counts for each of the 
2,879 genes—obtained from DESeq2 as described above—from the triplicates, ordered the list of 
genes from most- to least-highly differentially expressed between WT-MHV-infected- and 
mock-infected BMDMs, and imported the z-score-standardized log2-trasformed mean 
normalized count values into Cluster 3.0 software. Cluster 3.0 allows for hierarchical 
arrangement of gene lists using expression data by clustering together genes whose expression 
patterns are similar to each other (de Hoon et al. 2004).  Specifically, we used the default 
settings—the similarity metric “Pearson correlation (uncentered)” and the clustering method 
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“centroid linkage”—in order to mathematically arrange the genes based on expression 
similarities. Note that this is not the same as functional clustering/arrangement in that Cluster 3.0 
only utilizes expression data, and not gene-encoded functional information, in order to 
hierarchically arrange genes. In order to visualize the result of this clustering, the output file of 
Cluster 3.0 processing was imported into Java TreeView software, which generates heatmaps 
from Cluster 3.0 outputs (Saldanha 2004). The outcome of this clustering and visualization 
process is shown as a heatmap in Figure 14 in the Results chapter. By studying this heatmap, we 
identified 6 groups of genes—which had been arranged as such by Cluster 3.0—whose gene 
expression profiles between infection cohorts and over time warranted additional analysis. We 
used Java TreeView to extract the list of gene names that corresponded to each of these 6 groups, 
which are indicated with brackets in the heatmap in Figure 14.
Functional Clustering Analyses Using DAVID
In order to determine the general biological functions of the differentially-expressed 
genes identified from our experiments that are shown in Figure 14, we utilized DAVID 
(Database for Annotation, Visualization and Integrated Discovery; https://david.ncifcrf.gov/ 
gene2gene.jsp), which is a free online tool that allows for functional clustering (aka gene 
ontology) analyses of lists of genes (Huang et al. 2009a; Huang et al. 2009b). We submitted the 
list of gene names (obtained from Java TreeView) from each of the 6 groups indicated in Figure 
14 to DAVID and converted the gene names to Ensembl IDs, the latter of which are better suited 
for DAVID analyses. Not all genes corresponded to an Ensembl ID, which is not surprising 
given that many of the genes within the heatmap in Figure 14 are putative and/or have not yet 
been assigned any function. The lists of Ensembl IDs—one list per each of the 6 groups—were 
then submitted to DAVID for functional clustering analyses. Specifically, under the “Gene 
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Ontology” category, the chart associated with the “GOTERM_BP_DIRECT” result (which is 
always conspicuously highlighted in red, as it is one of the DAVID-defined defaults) was used 
for all 6 groups.
For each term in its output (a term corresponds to a functional cluster into which a given 
number of one’s input genes were clustered by DAVID), DAVID assigns a q-value that is 
determined based on the relative enrichment profiles of the genes from one’s input list of genes. 
For example, whether or not a list of input genes contains a statistically significant 
overrepresentation of “immune response” genes will be reflected in the q-value associated with 
the “immune response” term in the DAVID results page. Using these q-values, we excluded all 
functional cluster terms that were not statistically significant using a cutoff of q < 0.05. We then 
further organized the remaining terms into even fewer clusters based on general relationships 
between terms (i.e., “immune response,” “inflammation,” and other semantically similar 
DAVID-generated terms were organized together under the blanket term “immune response”). 
By creating a “sublist” in DAVID that included only the statistically significant functional 
clusters within each of the 6 groups, we determined the number of unique genes within each 
group that appeared in at least one functional cluster of statistical significance. The row z-score-
standardized log2-transformed normalized counts for these “unique genes in statistically 
significant functional clusters” were then plotted over time in heatmaps using the gplots package 
in RStudio, a free downloadable package and program, respectively, that together allow for the 





Evaluating Expression of Type I IFN in BMDMs during Infection with EndoU-mut-,    
DUB-mut-, and WT-MHV
Given the data from our lab and other groups demonstrating that nsp15-EndoU and nsp3-
DUB contain type I IFN antagonism activity, mutant viruses encoding catalytically deficient 
(EndoU-mut) or catalytically impaired (DUB-mut) versions of these proteins, shown in Figure 7, 
should elicit greater IFN responses during infection compared to the WT parental strain 
(Clementz et al. 2010; Mielech, Kilianski, et al. 2014; Deng et al. 2017; Kindler et al. 2017; 
Deng et al. manuscript in preparation). Indeed, published and unpublished data in which each 
mutant virus was used in separate experiments demonstrated that both EndoU-mut- and DUB-
mut-MHV-infected cells exhibited enhanced IFN production during infection relative to WT-
MHV infection (Deng et al. 2017; Kindler et al. 2017; Deng et al. manuscript in preparation). 
Importantly, however, the effects on the IFN response that are elicited by the two mutant strains 
have not been directly compared. Thus, we first evaluated the expression of type I IFN in the 
context of a timecourse infection with these 3 different viruses. Briefly, BMDMs were infected 
with   WT-, EndoU-mut-, or DUB-mut-MHV (MOI = 1.0) for 3, 6, 9, or 12 hr, after which 
timepoints total RNA was collected for subsequent analysis by quantitative reverse transcription 
polymerase chain reaction (qRT-PCR) (see Materials and Methods for primer information). RNA 
was also collected from mock-infected cells at 3 hpi and was used as a negative control for
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analyses of all timepoints. In Figure 11, the expression of Ifna11 is reported as fold-change 
relative to mock-infected cells (using the 2-∆∆Ct method) and is normalized to the expression of 
18S ribosomal RNA (18S rRNA) as an internal control. Statistical significance between infection 
groups was determined using two-tailed Student’s t-tests.
We found that BMDMs infected with either mutant virus expressed significantly higher 
(p < 0.05) amounts of a type I IFN—Ifna11— compared to BMDMs infected with WT-MHV at 
6, 9, and 12 hpi. No significant difference was found between groups at 3 hpi. Notably, while 
cells infected with either mutant virus exhibited significantly earlier and more robust IFN 
expression compared to WT-infected cells, these effects were most potent in the EndoU-mut-
infected groups at all timepoints (except 3 hpi). Thus, in addition to demonstrating the impaired 
ability of EndoU-mut- and DUB-mut-MHV to suppress IFN expression during infection, these 
experiments provided an initial indication that both mutant viruses being studied (Endo-mut- and 
DUB-mut-MHV), although similar in that each encodes a catalytically-deficient or impaired viral 
IFN antagonist, elicit distinct host responses during infection.
60
Figure 11. EndoU-mut- and DUB-mut-MHV Induce Significantly Higher Expression of 
Ifna11 during Infection of BMDMs. BMDMs were infected with EndoU-mut, DUB-mut, and 
WT-MHV at MOI = 1.0. Cells were lysed and total RNA was extracted at 3, 6, 9, and 12 hpi. 
RNA from mock-infected cells at 3 hpi was included in analyses of all timepoints as a negative 
control. Total RNA from each sample was converted to cDNA, which was then evaluated for 
expression of Ifna11 and 18S rRNA, the latter of which served as an internal control. Expression 
of Ifna11 is reported as fold-change relative to mock-infected cells (normalized to 18S rRNA 
expression) and was calculated via the 2-∆∆Ct method using the following equation: 2-[(Ct(Ifna11) − 
Ct(18S rRNA))test sample – (Ct(Ifna11) − Ct(18S rRNA))mock group]. Statistical significance between infection groups 
within each timepoint was determined using two-tailed Student’s t-tests. ** p < 0.01; *** p < 





















































































































































































































Evaluating Expression of Nucleocapsid Gene in BMDMs during Infection with EndoU-
mut-, DUB-mut-, and WT-MHV
To determine if the mutant viruses exhibited any differences in viral gene expression, we 
evaluated the expression of nucleocapsid (N) gene in the context of a timecourse infection with 
these different viruses (Figure 12). Evaluating the levels of N gene transcript over time is a 
method of indirectly assessing CoV replication kinetics since N gene mRNA levels increase as 
wild type viral infection progresses and nucleocapsid protein is essential for the packaging of 
coronaviral genetic material into assembling virions (Irigoyen et al. 2016; Kuo et al. 2016). The 
same RNA samples from the experiment described in Figure 11 were also used to evaluate N 
gene expression by qRT-PCR. In Figure 12, the expression of N gene is reported as fold-change 
relative to WT-MHV-infected cells (since there was no detectable expression of N gene in mock-
infected samples) and is normalized to the expression of 18S rRNA. Fold induction was 
calculated using the following equation: 2-[Ct(N gene) − Ct(18S rRNA)]. Statistical significance between 
infection groups was determined using two-tailed Student’s t-tests.
We found no significant difference between relative expression levels of N gene in WT- 
and DUB-mut-MHV-infected BMDMs at any timepoint, indicating that the IFN induction 
observed in the context of DUB-mut-MHV infection (Figure 11) was not sufficient to interfere 
with replication of DUB-mut-MHV. In contrast, levels of N gene transcript were significantly 
lower in EndoU-mut-MHV-infected BMDMs than in WT- or DUB-mut-MHV-infected cells at 
6, 9, and 12 hpi. Notably, the timing of this decreased N gene expression in EndoU-mut-MHV-
infected BMDMs inversely mirrored the timing of the Ifna11 expression profile that was elicited 
during infection with the EndoU-mut virus (Figure 11). This relationship suggests that the 
inability of mutant EndoU to antagonize the IFN response during infection contributed to the 
62
observed attenuated expression of N gene during infection of WT-BMDMs with EndoU-mut-
MHV. No significant difference in the expression of N gene between infection groups was 
observed at 3 hpi.
Figure 12. Expression of Viral Nucleocapsid Gene is Attenuated during Infection of 
BMDMs with EndoU-mut- but not DUB-mut-MHV. BMDMs were infected and RNA was 
collected for qRT-PCR as described in Figure 11. Expression of viral nucleocapsid (N) gene is 
reported as fold-change relative to WT-MHV-infected cells (normalized to 18S rRNA 
expression) and was calculated via the 2-∆∆Ct method using the following equation: 2-[(Ct(Ifna11) − 
Ct(18S rRNA))test sample – (Ct(Ifna11) − Ct(18S rRNA))WT group]. Statistical significance between infection groups 
within each timepoint was determined using two-tailed Student’s t-tests. ** p < 0.01; *** p < 










































































































































































































Taken together, the qRT-PCR timecourse experiments in Figures 11 and 12 demonstrate 
that EndoU-mut- and DUB-mut-MHV triggered an earlier and more robust type I IFN response 
in WT-BMDMs compared to WT-MHV, indicating that the wild type versions of EndoU and 
DUB proteins both function as IFN antagonists. Additionally, the observed differences in the 
expression of Ifna11 and N gene between EndoU-mut- and DUB-mut-MHV suggest that the 
endoribonuclease activity of nsp15 is a more potent suppressor of the IFN response than the 
deubiquitinase activity of nsp3, given that a catalytic mutation in nsp15-EndoU dramatically 
impaired the expression of at least one viral gene, while a catalytically impaired nsp3-DUB 
exhibited WT-like viral gene expression kinetics. These results provided rationale for subsequent 
RNA-seq experiments, the goal of which was to determine the global transcriptional effects—
with particular interest in the transcription of genes whose protein products are involved in innate 
antiviral immunity—that are elicited during infection with these different strains of MHV.
Global Gene Expression Induced by EndoU-mut-, DUB-mut-, and WT-MHV in BMDMs
To obtain a comprehensive, global view of how WT-, EndoU-mut-, and DUB-mut-MHV 
shape the antiviral innate immune response during infection, RNA-seq was applied to RNA 
samples from virus-infected BMDMs at multiple timepoints. Specifically, BMDMs were 
infected with WT-, EndoU-mut-, or DUB-mut-MHV (MOI = 1.0) in quadruplicate and total 
RNA was isolated from whole cell lysates at 3, 6, 9, and 12 hpi. As above, RNA was also 
collected from mock-infected cells at 3 hpi to be used as a negative control for analyses of all 
timepoints. RNA samples—which included both host and viral RNAs—were then submitted in 
triplicate to the University of Chicago Genomics Facility, where samples first underwent poly-A 
selection to separate mRNAs from rRNAs. Total mRNA from each sample was then subjected to 
quality control (QC) analysis by Bioanalyzer technology. Results of QC tests on all samples are 
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reported as RNA integrity numbers (RINs) in Table 2, with a maximum RIN value of 10 
corresponding to the highest obtainable RNA quality (Schroeder et al. 2006). All samples were 
of sufficient quality for RNA-seq; however, we note that the RNA from each of the EndoU-mut-
MHV-infected replicates at 12 hpi were of lower quality than all other groups, possibly 
indicating that BMDMs infected with EndoU-mut-MHV—but not DUB-mut- or WT-MHV—
endured some level of RNA degradation by 12 hpi. After passing quality control, cDNA libraries 
were generated from total mRNA from each sample and libraries were subsequently subjected to 
next-generation single-read 50 base pair (SR50) sequencing by Illumina technology. 
Approximately 4 x 107 total reads—which, in virus-infected samples, included reads of both host 
and viral origin—were generated from each sample (3 replicates per infection condition per 
timepoint) for a total of approximately 1.6 x 109 reads across all samples from all timepoints.
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RIN Value
Replicate 1 Replicate 2 Replicate 3
Mock 10 10 10
WT 10 10 10
3 hpi DUB-mut 10 10 9.5
EndoU-mut 10 10 10
WT 10 10 10
6 hpi DUB-mut 10 10 10
EndoU-mut 10 10 10
WT 10 10 10
9 hpi DUB-mut 10 10 10
EndoU-mut 9.8 9.9 9.6
WT 10 8.2 10
12 hpi DUB-mut 10 10 10
EndoU-mut 8.5 8.4 8.2
Table 2. RIN Values of Samples Submitted for RNA-seq. Prior to applying RNA-seq to 
submitted samples, QC analyses were performed using Bioanalyzer technology to determine the 
quality of the RNA in each sample. Shown are the results of these QC analyses, reported as RIN 
values that are a relative indication of RNA quality, for each of the 3 replicates for each infection 
group across all 4 timepoints. A value of 10 represents the highest quality RNA.
To extract biologically-relevant information from the sequencing information that was 
generated from each RNA sample, the total reads were then analyzed using an established RNA-
seq bioinformatic analysis pipeline through an online platform called Galaxy (Afgan et al. 2016). 
This pipeline is outlined schematically in Figure 13 (see Materials and Methods for an in-depth 
explanation of each step). Briefly, residual barcode sequences—unique to each sample—were 
clipped from all reads and clipped reads originating from the same sample were then 
concatenated into a single file per sample. Next, each concatenated file containing clipped reads 
was “groomed” to ensure that all reads were in the appropriate Sanger FASTQ format that is 
required for downstream analyses. Groomed reads were then aligned to the C57BL/6J murine 
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genome using the tool HISAT2 (Kim et al. 2015). The sequence and annotation files of the 
GRCm38 Ensembl build of the mouse genome were downloaded from Illumina’s iGenomes 
website. After using HISAT2, all reads that did not successfully align to the reference genome 
were discarded; for virus-infected samples, this step was important to eliminate those reads that 
originated from viral mRNAs. The reads in each sample that aligned with the sequence of an 
annotated gene in the reference genome were then counted by featureCounts and those “raw” 
counts were used along with the tool DESeq2 to calculate differential expression values for each 
gene between each of the 4 treatment groups (WT-MHV-, EndoU-mut-MHV-, DUB-mut-MHV-, 
and mock-infected BMDMs) (Liao et al. 2014; Love et al. 2014). Importantly, DESeq2 
transforms “raw” counts for each gene in each sample into “normalized” count values, the latter 
of which it then uses to calculate fold-change in expression between groups. Raw count values 
are normalized by DESeq2 to take into account size differences between samples; for example, if 
2 x 106 reads from one sample aligned to the reference genome, but 3 x 106 reads from another 
sample aligned to the same genome, then DESeq2 takes those differences into account by scaling 
the raw reads for a given gene across all compared samples (Love et al. 2014).
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Figure 13. RNA-seq Data Analysis Pipeline. Raw RNA-seq data in the form of reads (strings 
of nucleotide sequences) were processed using Galaxy’s online platform in order to generate 
differential gene expression data between infection groups. Reads were first clipped to remove 
any residual unique barcode sequences that were originally added during preparation of each 
RNA sample for sequencing. Reads were then concatenated to combine multiple files per sample 
into a single file for each sample. Combined files were then groomed to ensure that all reads 
were in Sanger FASTQ format. Next, reads were aligned to the GRCm38 Ensembl build of the 
C57BL/6J mouse genome using HISAT2 aligner, which locates the region of the genome to 
which each read corresponds. Because most samples contained both viral and mouse RNA, the 
first alignment step was used to weed out all reads that did not correspond to any location along 
the mouse genome. All reads not aligning to the mouse genome (i.e., reads that originated from 
viral RNA) were discarded to reduce file sizes. The remaining murine-only reads were re-aligned 
to the mouse genome to obtain an output BAM file for each sample. BAM files contained the 
alignment information for each read in that sample and were used as inputs into featureCounts, 
which counts the number of reads in each sample that corresponds to each gene in the mouse 
genome. Finally, the outputted count data from featureCounts was used as the input for DESeq2 
to calculate differential expression for each gene across all samples and treatment groups. In 
addition to differential gene expression and fold-change data, DESeq2 generated normalized 
count values for each gene in all samples. These normalized counts are intended to correct for 
size differences between samples that might otherwise skew differential expression calculations 
if some samples contain substantially more or fewer total reads than the others. These values are 
plotted and visualized in a variety of ways, as shown in Figures 14, 16-19, and 21.
After applying this pipeline to our raw reads and obtaining as an output expression 
information for each gene across all samples, we next sought to identify and analyze 
differentially-expressed genes (DEGs) between infection groups. We used as a starting point the 
list of DEGs between mock and WT-MHV-infected BMDMs at 12 hpi that was generated as an 
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output by DESeq2. We filtered this list of genes based on the statistical significance associated 
with the fold-change differential expression value. A q-value (aka adjusted p-value, calculated by 
DESeq2 for each gene in each comparison using the Benjamini-Hochberg procedure) of < 0.05 
was chosen as the cutoff for statistical significance; genes whose differential upregulation values 
did not meet this cutoff in WT-MHV-infected BMDMs at 12 hpi compared with mock-infected 
cells were removed from the list (Love et al. 2014). Next, a differential expression magnitude 
cutoff of > 4 was applied to the remaining genes; genes that were not more highly expressed by 
at least 4-fold in WT-MHV-infected cells at 12 hpi compared to mock were removed from the 
list. After applying these cutoffs, 2,879 genes remained and were arranged in order of most- to 
least-highly upregulated in WT-MHV-infected cells at 12 hpi compared to mock. Cluster 3.0 
software was then used to apply mathematical clustering to the z-score-standardized log2-
normalized mean normalized count values associated with each gene in each timepoint and 
infection group (de Hoon et al. 2004). Specifically, the default settings—the similarity metric 
“Pearson correlation (uncentered),” and the clustering method “centroid linkage”—were applied 
to the list of 2,879 genes and the corresponding expression values for each gene across all 
samples to produce a hierarchically-clustered gene list based on how similar or different the 
expression patterns were between groups of genes across all samples. This new list of clustered 
genes and their associated expression values was then visualized as a heatmap using Java 
TreeView software, which is shown in Figure 14 (Saldanha 2004). Figure 14 depicts global 
differences in gene expression between WT-, EndoU-mut-, and DUB-mut-MHV-infected 
BMDMs. Plotted are row z-score-standardized log2-transformed normalized counts for each of 
the 2,879 different murine genes across all timepoints and infection groups. The normalized 
counts represent the average of the replicates for a given timepoint and infection group. The 
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names of all 2,879 genes in Figure 14 are listed, in the same order in which they are clustered in 
the heatmap, in Table S1 in the Appendix of this document.
Figure 14. Global Expression Profiles of EndoU-mut-, DUB-mut-, WT-MHV, and Mock-
infected BMDMs. Total RNA was extracted from EndoU-mut-, DUB-mut-, and WT-MHV-
infected BMDMs at 3, 6, 9, and 12 hpi. Samples were poly-A-selected to enrich mRNAs 
(without eliminating viral RNAs, which resemble host mRNAs) and subjected to SR50 
sequencing by Illumina technology. Raw reads were processed as described in Figure 13 to 
generate differential expression data and normalized counts for each gene in each sample. Next, 
the expression data from WT-MHV-infected BMDMs at 12 hpi was compared with mock-
infected cells; a statistical significance cutoff of q < 0.05 and a fold-change cutoff of > 4 were 

















applied to select only the most highly differentially-expressed genes. The normalized counts for 
the 2,879 genes that met these cutoffs were averaged across replicates and converted to log2-
transformed z-scores, which were then imported into Cluster 3.0 software to mathematically 
arrange the gene list based on similarity in expression patterns between samples via the Pearson 
correlation (uncentered) and centroid linkage metrics. Finally, Java TreeView software was used 
to visualize the output from Cluster 3.0, the outcome of which is shown here. Plotted are row z-
score-standardized log2-transformed values for each gene across all samples and timepoints. The 
color bar indicates the approximate row z-score that is associated with each color, with warmer 
colors corresponding to higher relative expression values in each row and cooler colors 
corresponding to lower relative expression values. Bracketed on the right are 6 groups of genes 
that we selected for subsequent analyses.
The global patterns of gene expression over time that are illustrated in Figure 14 indicate 
that the transcription of these 2,879 genes in response to WT- and DUB-mut-MHV infection in 
BMDMs was remarkably similar over time, whereas the response to EndoU-mut-MHV infection 
was profoundly distinct. In other words, the absence of an enzymatically active EndoU protein—
but not the absence of a fully functional DUB protein—was sufficient to elicit dramatic 
differences in the transcriptional response to infection compared to WT-MHV infection. These 
results therefore suggest that the enzymatic activity of the WT-EndoU protein broadly regulates 
the cellular response to infection, whereas the WT-DUB protein participates in a much narrower 
range of regulatory processes. To further differentiate between the transcriptional profiles of the 
different infection groups, we next individually analyzed several groups of genes from the 
heatmap in Figure 14.
Functional Clustering/Gene Ontological Analyses of Differentially-Expressed Genes
We bracketed several distinct groups of genes within the heatmap in Figure 14 and 
numbered them 1-6. We sought to determine if these groups of genes, which had already been 
mathematically clustered together in Figure 14 based on similarities in their expression patterns, 
encode proteins that also have similar functions. Figure 15 shows a schematic of the pipeline that 
we employed to analyze these groups of genes denoted in Figure 14. Briefly, the list of gene 
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names within each group was converted to the corresponding Ensembl IDs, and those IDs were 
subjected to gene ontological (aka functional clustering) analyses using an online tool called 
DAVID (Database for Annotation, Visualization and Integrated Discovery) (Huang et al. 2009a; 
Huang et al. 2009b). DAVID is a valuable tool for clustering lists of genes based on functional 
similarities of the proteins that they encode; for example, if a list of genes contains multiple 
known pro-inflammatory genes, they will be clustered together under a blanket term like 
“inflammation” or “inflammatory response.” Additionally, each functional cluster is associated 
with a q-value that is indicative of the false-discovery rate (FDR, via the Benjamini-Hochberg 
Procedure) and represents the statistical significance of a given cluster. A cluster generated by 
DAVID will meet statistical significance (which we defined as q < 0.05) if it contains a sufficient 
number of genes to be considered a non-random enrichment of the functional group in the 
context of the full list of genes that was originally submitted to DAVID for analysis. Table 3 
shows the results of these DAVID analyses for each of the 6 groups of genes denoted in Figure 
14. The column labeled “Total genes in group” refers to the total number of genes in each group 
that were submitted to DAVID for gene name conversion and subsequent clustering; notably, not 
all of these genes correspond to Ensembl IDs and not all Ensembl IDs were ultimately clustered 
by DAVID into clusters of statistical significance. The column titled “Statistically significant 
functional clusters within group” shows the functional clusters within each group that were 
statistically significant. As there was substantial redundancy among many of the clusters, we 
further organized the functional clusters into groups of essentially redundant terms (e.g., 
“immune response” represents functional cluster terms such as “immune response,” 
“inflammatory response,” “inflammation,” etc.). “Unique genes in statistically significant 
clusters” refers to the total number of genes in each group that were clustered into at least one of 
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the functional clusters that met statistical significance in that group. A gene that appears in 
multiple clusters of statistical significance is counted as one unique gene. In this way, as outlined 
in Figure 15, we extracted all of the unique, statistically significant functionally-clustered genes 
from the groups in Figure 14. As shown in Table 3, genes in Groups 5 and 6 were not clustered 
by DAVID into any clusters of statistical significance, indicating that the genes within those 
groups are not highly functionally similar despite having been grouped together based on similar 
expression patterns. Therefore, Groups 5 and 6 were not further analyzed. We next generated 
heatmaps of the expression profiles of the unique genes in statistically significant functional 
clusters from each of the remaining 4 groups, which are shown in Figures 16-19. The names of 
the genes whose expression profiles are displayed in the heatmaps Figures 16-19 are listed, in 
order, in Tables S2-S5 in the Appendix of this document. Finally, the unique, functionally-
clustered genes within each group were ordered from most- to least-highly upregulated in terms 
of their expression levels in WT-MHV-infected BMDMs at 12 hpi compared to mock-infected 
BMDMs, and the normalized counts for the top 12 genes from each group whose expression was 
associated with at least 100 normalized counts in any sample were plotted over time. These line 
graphs are displayed in Figures 16-19.
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Figure 15. Schematic of Analysis and Data Presentation Methods Applied to Genes in 
Groups 1-6. After generating the heatmap in Figure 14 (top bubble), 6 groups of genes of 
interest (labeled Groups 1-6) were identified from the heatmap based on noteworthy patterns of 
heatmap of global gene expression
(Figure 14)
 Heatmap contains expression data for the most highly upregulated genes in 12 hpi WT-
MHV-infected cells compared with mock-infected cells.
o fold-change minimum cutoff: 4
o q-value cutoff: 0.05
o 2,879 genes total
o Genes are arranged based on expression pattern similarities using Cluster 3.0.
6 groups of genes of interest
(Figure 14)
• identified from heatmap in Figure 14
functional clustering/gene ontology
(Table 3)
• The gene names from each group were first converted to Ensembl IDs 
using DAVID.
• Ensembl IDs from each group were then submitted to DAVID for 
functional clustering.
heatmaps of unique genes in statistically significant functional clusters
(Figures 16A-19A)
• Statistically significant clusters of genes were identified within Groups 1-4 using 
DAVID analyses.
• Heatmaps contain the expression data for these genes, broken down by group into 
separate figures (log
2
-transformed, z-score-standardized normalized counts).
line graphs of top statistically significant functionally-clustered genes
(Figures 16B-19B)
• Unique genes within statistically significant functional clusters for Groups 1-4 were ordered from 
most to least upregulation in WT-MHV-infected cells at 12 hpi compared to mock-infected cells.
• The normalized counts of the top 12 genes from each group that met the normalized count 
minimum of 100 were then plotted in line graphs over time.
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expression across infection groups (second bubble). The gene names in each group were 
converted to Ensembl IDs using DAVID and the resulting lists of Ensembl IDs were submitted 
to DAVID for functional clustering analyses (third bubble). The results of these analyses are 
shown and described in Table 3. The expression patterns of each of the unique genes from 
statistically significant functional clusters within each group were then plotted in a separate 
heatmap for each group, shown in Figures 16A-19A (fourth bubble). Finally, the top 12 unique 
genes from statistically significant functional clusters within each group were then selected based 
on highest degree of upregulation in WT-MHV-infected cells at 12 hpi compared with mock-
infected cells with a minimum normalized count cutoff of at least 100 counts; the normalized 





Statistically significant functional 
clusters within group
















transcription and cell proliferation (6)
apoptosis (5)








5 491 none N/A
6 91 none N/A
Table 3. Functional Clustering Analyses of Gene Groups 1-6 Using DAVID. Genes from 
each of the 6 groups bracketed in Figure 14 were submitted to DAVID for functional clustering, 
as described in Figure 15. Shown here are the results of these analyses, including the total genes 
in each group that were originally submitted to DAVID for clustering (second column), the 
number of statistically significant functional clusters within each of the 6 groups as determined 
by DAVID (third column), and the number of unique genes that appear in at least one of the 
statistically significant functional clusters within each group (last column). Because DAVID 
reported many functional clusters that were semantically redundant, we further condensed the 
75
results of these DAVID analyses into the clusters shown in the third column. The number in 
parentheses after each of the terms listed in the third column indicates the number of statistically 
significant DAVID-generated clusters that we condensed into each larger cluster (i.e., we binned 
60 statistically significant functional clusters within Group 3 into the “immune response” term 
shown in the third column). Groups 5 and 6 were not associated with any functional clusters of 
statistical significance. N/A, not applicable.
Note that the reads from the same 3 hpi mock-infected BMDMs were included as a 
negative control during analyses of all timepoints and are also plotted in all panels in Figures 16-
19. Due to the process by which DESeq2 normalizes counts across samples, which corrects for 
differences in the total number of mapped reads between samples, it may appear in some 
individual line graphs within Figures 16-19 as though the number of reads from the same mock-
infected samples are somehow decreasing over time. However, this trend is merely an artifact of 
the read normalization process and is due in this case to the fact that the total number of reads 
mapping to the murine host genome decreased in MHV-infected samples as infection progressed. 
In other words, the total number of murine reads in an MHV-infected sample at 12 hpi was 
significantly lower than the number of murine reads in a mock-infected sample at 3 hpi because 
expression of the viral genome dominates cellular transcription machinery in MHV-infected cells 
by 9-12 hpi. DESeq2 accounts for these differences in sequencing depth by scaling up or down 
the number of raw counts that were mapped to each gene in each sample according to a “scaling 
factor” that is calculated from the average of the number of reads pertaining to that gene across 
all samples included in the analysis. The authors of the DESeq2 package describe this process in 
detail in their 2014 paper (Love et al. 2014). It is therefore best to compare the normalized 
counts pertaining to each sample against the other samples in that same timepoint (i.e., compare 
the normalized counts for a particular gene in WT-MHV-infected samples at 12 hpi with the 
normalized counts for that same gene in EndoU-mut-MHV-, DUB-mut-MHV-, or mock-infected 
cells at 12 hpi).
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The data in Table 3 indicate that genes involved in the immune response, transcription, 
and various signaling cascades appear in multiple groups in the heatmap in Figure 14. This 
scattering of functionally similar genes throughout the heatmap is a consequence of the method 
of clustering that was used to generate Figure 14, which involved ordering the genes based on 
their expression patterns and not based on their functions. Additionally, it is notable that Group 3 
contained the highest number of functional clusters of statistical significance (95) despite having 
the third-lowest number of total genes of all 6 groups. However, most of these clusters within 
Group 3 were essentially redundant (60 clusters were various iterations of “immune response” 
genes, for example) and most of the 203 unique genes in Group 3 were clustered by DAVID into 
more than one functional cluster.
Group 1.
The 4 groups containing genes that were organized by DAVID into statistically 
significant functional clusters (Groups 1-4) can be classified in terms of the gene expression 
profile associated with EndoU-mut-MHV-infected BMDMs in each group. Thus, Group 1 
contains genes that were most highly expressed in EndoU-mut-MHV-infected cells; Group 2, on 
the other hand, includes genes that were least highly expressed in EndoU-mut-MHV-infected 
cells; and Groups 3 and 4 comprise genes that were associated with an intermediate expression 
phenotype induced by EndoU-mut-MHV relative to the other two groups. Notably, the unique 
genes in statistically significant functional clusters within Group 1—all of which were most 
highly expressed during EndoU-mut-MHV infection—include a number of type I IFN genes 
(Figure 16A). Indeed, 17 of these 30 genes are type I IFN isoforms. Because the top 12 most 
upregulated unique genes from Group 1 in WT-MHV-infected cells at 12 hpi compared with 
mock-infected cells were all type I IFN isoforms with virtually indistinguishable expression 
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profiles, we elected to show only 9 of these isoforms and selected 3 other genes from the Group 
1 list—Lta, Oas1b, and Isg15—to display in line graphs Figure 16B. All of the genes in Figure 
16B encode proteins that are known to participate in the antiviral response. Importantly, these 
data indicate that EndoU-mut-MHV elicited a substantially higher type I IFN response than the 
other two viruses while simultaneously pointing to a similar—yet much subtler—increase in 
expression of the same type I IFN genes during DUB-mut-MHV infection compared to WT-
MHV infection. Our RNA-seq data therefore corroborate the results of qRT-PCR experiments in 
Figure 11. 
Group 1 Heatmap





Group 1 Line Graphs
Figure 16. Expression Profiles of Unique Genes in Statistically Significant Functional 
Clusters within Group 1. After applying DAVID functional clustering to Groups 1-6 from 
Figure 14, the expression profiles of the unique genes in statistically significant functional 
clusters within Group 1 were plotted as heatmaps and line graphs to emphasize differences in 
patterns of expression between EndoU-mut-, DUB-mut-, and WT-MHV-infected BMDMs over 
time (see Table 3). (A) Plotted are row z-score-standardized log2-transformed means of 
replicates for all samples. Color bar shows the row z-sore value associated with each color shade, 





























































































































































































































































































































with warmer colors representing higher relative expression values within a row and cooler colors 
corresponding to lower relative expression values. See Table S2 in the Appendix for a list of 
gene names in the order in which they appear in this heatmap. (B) The normalized count values 
for the top 12 unique genes in statistically significant functional clusters within Group 1 are 
plotted as line graphs. These genes were chosen by ordering the list of unique genes in 
statistically significant functional clusters within each group from most- to least-highly 
upregulated in WT-MHV-infected cells at 12 hpi compared with mock-infected cells. The top 12 
genes from each of those lists that was associated with at least 100 normalized counts in any 
sample were selected. For this group only (and not for Groups 2-4), since the top 12 genes were 
all type I IFN isoforms with nearly identical expression patterns, we elected to show only 9 of 
these isoforms and selected 3 other genes from the Group 1 list—Lta, Oas1b, and Isg15—to 
display here. Plotted are the average normalized counts for each gene in EndoU-mut- (green), 
DUB-mut- (blue), WT-MHV- (lilac), and mock-infected (black) BMDMs infection groups over 
all 4 timepoints. The normalized counts from each infection group at 12 hpi were subjected to 
statistical testing using two-tailed Student’s t-tests. * p < 0.05; ** p < 0.01; *** p < 0.001; **** 
p < 0.0001; ns, not significant. Data are presented as means ± SD.
Group 2.
Unlike in Group 1, the unique genes in statistically significant functional clusters within 
Group 2, whose expression profiles are shown in a heatmap in Figure 17A, were least highly 
expressed in EndoU-mut-MHV-infected cells compared with DUB-mut- and WT-MHV-infected 
cells. The majority of these genes encode proteins that act in transcription (Table 3), a few of 
which appear to have been differentially expressed between DUB-mut- and WT-MHV-infected 
cells. The normalized counts for some of these genes are plotted in line graphs in Figure 17B.
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Group 2 Heatmap





Group 2 Line Graphs
Figure 17. Expression Profiles of Unique Genes in Statistically Significant Functional 
Clusters within Group 2. See Figure 16 for figure legend. See Table S2 for a list of gene names 
in the order in which they appear in this heatmap.
















































































































































































































































































































The unique genes in statistically significant functional clusters within Groups 3 and 
Groups 4 were, in general, least highly expressed in EndoU-mut-MHV-infected cells (albeit still 
more highly expressed in these cells than were the genes in Group 2). Group 3 most notably 
contains a number of canonical pro-inflammatory cytokines and chemokines (Tnf, Il1a/Il1b, Il6, 
Il12a/Il12b, Csf1, Cxcl10, Cxcl11, among others), a host of known antiviral defense genes and 
sensors of viral infection (including Ifit1/Isg56, Ifit2, Ifit3, Ddx58/RIG-I, and Eif2ak2/PKR), as 
well as genes involved in the regulation of NF-κB activation and signaling (including Rel/NF-
κB, IκBα, IκBδ, and Ikbke). The expression profiles of these genes are shown in a heatmap and 
line graphs in Figures 18A and 18B, respectively. Unlike the genes in Groups 1 and 2, the genes 
in Group 3 generally were not associated with a statistically significant differential expression 
profile in DUB-mut-MHV-infected cells compared with WT-MHV-infected cells. Together, the 
data in Figure 18 strongly suggest that the macrophages infected with EndoU-mut-MHV were in 
a significantly less pro-inflammatory state than were the cells infected with either DUB-mut- or 
WT-MHV. The data also indicate that DUB-mut- and WT-MHV appear to have elicited 
inflammatory and antiviral responses of similar magnitude, as evidenced by the overwhelming 
lack of statistically significant differences in gene expression between the DUB-mut- and WT-









Group 3 Line Graphs
Figure 18. Expression Profiles of Unique Genes in Statistically Significant Functional 
Clusters within Group 3. See Figure 16 for figure legend. See Table S4 for a list of gene names 
in the order in which they appear in this heatmap.















































































































































































































































































































Finally, similar to Group 2, the majority of the unique genes in statistically significant 
functional clusters within Group 4 encode proteins that are involved in transcription, most 
commonly by acting as transcription factors or molecules that participate in signaling cascades 
that terminate in large-scale transcriptional changes (Table 3). The expression profiles of these 
genes are shown in a heatmap and line graphs in Figure 19. Interestingly, in addition to being 
significantly less highly expressed in EndoU-mut-MHV-infected cells, many of the in Group 4 
were also associated with statistically significant differential expression between DUB-mut- and 
WT-MHV infection groups, demonstrated by the line graphs in Figure 19B. We note that several 
of these genes—including Plagl1, Kalm, Zfhx4, Asap3, and others—were in fact most highly 
induced by DUB-mutant-MHV infection. A few other genes were not differentially expressed at 
all between virus-infected groups. The data in Figures 17-19 (which display the expression data 
from the genes in Groups 2-4, respectively) indicate that the macrophages infected with EndoU-
mut-MHV were much less transcriptionally active than were the cells infected with DUB-mut- or 
WT-MHV. Taken together, the results of our RNA-seq experiments, including the functional 
clustering analyses that we applied to groups of DEGs, provide compelling data to suggest that 
DUB-mut-MHV elicited matching expression patterns of all but a select few genes compared 
with WT-MHV, whereas EndoU-mut-MHV induced a profoundly distinct transcriptional 
response that differentially impacted the expression of more than 2,800 genes. Potential 
mechanisms that may contribute to the dysregulation of genes in Groups 1-6 are described in the 
Discussion chapter of this document.
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Group 4 Heatmap





Group 4 Line Graphs
Figure 19. Expression Profiles of Unique Genes in Statistically Significant Functional 
Clusters within Group 4. See Figure 16 for figure legend. See Table S5 for a list of gene names 
in the order in which they appear in this heatmap.
































































































































































































































































































































The work described herein is, to the best of our knowledge, the first report of applying 
global transcriptome profiling to an immune cell type infected with a mutant coronavirus or the 
WT parental strain. Using virus-infected primary murine BMDMs, we report that both EndoU-
mut- and DUB-mut-MHV induced significantly elevated expression of multiple type I IFN 
isoforms relative to WT-MHV as early as 6 hpi, with EndoU-mut-MHV-infected BMDMs 
expressing the highest levels of these transcripts (Figures 11 and 16). Interestingly, aside from 
these type I IFN genes and a handful of other genes that were most highly expressed during 
EndoU-mut-MHV infection, the vast majority of the 2,879 genes that were most highly 
upregulated during WT-MHV infection at 12 hpi relative to mock were, by comparison, least 
highly expressed in EndoU-mut-MHV-infected cells (Figure 14). Functional clustering analyses 
revealed that these genes comprised a host of canonical pro-inflammatory cytokines (including 
Tnf, Il6, Il1, and Il2, along with multiple chemokines), antiviral defense genes and sensors of 
viral infection, regulators of NF-κB activity, as well as a number of other genes that are known 
to be involved in the induction and/or regulation of transcription (Figures 17-19). These findings 
are in line with a recent report describing the expression profiles of 754 genes in BMDMs 5-14 
dpi with a gliatropic strain of MHV, in which the authors describe the upregulation of a large 
cluster of pro-inflammatory genes (Savarin et al. 2018). Interestingly, Cheung et al. (2005) also 
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demonstrated upregulation of several chemokines by 3 hpi in SARS-CoV-infected primary 
human monocyte-derived macrophages, whereas we did not observe any differential expression 
at all until 6 hpi. We speculate that this disparity is a product of temporally distinct responses 
elicited by SARS-CoV and MHV.
Despite containing a marked increase in type I IFN mRNAs during DUB-mut-MHV 
infection, BMDMs infected with this strain exhibited a transcriptional response that was 
statistically indistinguishable from that induced by WT-MHV at all timepoints with few 
exceptions. It is noteworthy that the widespread transcriptional changes associated with EndoU-
mut-MHV infection, for which but a single amino acid change in nsp15 was responsible, were 
accompanied by attenuation of the virus, whereas neither DUB-mut- nor WT-MHV was 
attenuated (Figure 12). These results indicate that the mere induction of type I IFN in the context 
of an IFN antagonist-deficient coronavirus is not a sufficient marker for attenuation of the virus 
or for substantial transcriptional dysregulation of host genes in response to the infection; instead, 
the magnitude of type I IFN expression is key. That EndoU-mut-MHV induced a profoundly 
higher type I IFN response than even the DUB-mut virus suggests that there is a threshold of IFN 
expression that must be crossed before a host macrophage mounts a differential response to an 
IFN antagonist-deficient coronavirus that is capable of mitigating the infection.
Impact of IFN Expression and Signaling.
Our data indicate that substantial expression of type I IFNs occurred early during 
infection (by 6 hpi) with each of the 3 viruses used in this study, albeit to profoundly different 
degrees depending on the particular virus (Figures 11 and 16). However, it is important to note 
that the expression of IFN isoforms that we observed during our experiments may not have 
prompted substantial IFN signaling or IFN-induced gene expression within the temporal 
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constraints of the timecourse. We previously reported that IFN-α is first detectable in the 
supernatants of EndoU-mut- and WT-MHV-infected BMDMs between 8 and 12 hpi; in order to 
influence gene expression, that secreted IFN must then interact with its receptor (IFNAR) on the 
surfaces of cells in a paracrine or autocrine manner, triggering a signaling cascade that 
eventually terminates in altered gene expression (Ivashkiv and Donlin 2014; Deng et al. 2017). 
Thus, it is unclear if the enhanced expression of type I IFN that we observed in the context of 
EndoU-mut- and DUB-mut-MHV infection of BMDMs ultimately influenced the global 
transcriptional profiles of those cells. Although a handful of groups have published the 
expression data for a select few genes upon treatment with type I IFN, to our knowledge there 
exist no published data illuminating the transcriptional profiles of type I IFN-treated 
macrophages with which we could compare the data that we obtained in this study (Zhou et al. 
2010; Pertsovskaya et al. 2013; Kroetz et al. 2015; Labzin et al. 2015). We aim to investigate the 
global transcriptional changes induced in macrophages by type I IFN alone in the near future. 
From the current study, we conclude that the magnitude and timing of the expression of type I 
IFN represent a useful marker for virus attenuation when studying IFN antagonist-deficient 
coronaviruses, but whether or not the attenuation of such mutant viruses is due to the induction 
and downstream signaling of type I IFN remains to be elucidated.
Mechanisms of Extensive Transcriptional Changes during CoV Infection
Apoptosis.
Why was global transcription in EndoU-mut-MHV-infected cells dramatically 
diminished relative to the other two infection groups and why did these cells appear to be 
significantly less pro-inflammatory in their gene expression profiles despite expressing the 
highest levels of type I IFNs? One possibility stems from the observation that the replication of 
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EndoU-mut-MHV is rapidly attenuated during infection of BMDMs compared with DUB-mut- 
and WT-MHV infection (Figure 12). This early attenuation of EndoU-mut-MHV replication 
might ultimately mean that macrophages infected with EndoU-mut-MHV, but not DUB-mut- or 
WT-MHV, were not sufficiently activated to increase the transcription of the pro-inflammatory 
genes. But what is responsible for disrupting the replication of EndoU-mut-MHV as early as 6 
hpi? We and others previously demonstrated that nsp15-EndoU limits apoptosis in macrophages 
during infection; therefore, it might be the case that BMDMs infected with EndoU-mut-MHV 
sensed the mutant virus (via the PKR and OAS/RNase L pathways, as we have shown) and 
subsequently began the process of apoptosis so early during infection that the infected cells 
simply did not have a chance to initiate a broad pro-inflammatory state before dying (Lei et al. 
2013; Deng et al. 2017). Additional work is required to clarify the intriguing and apparently 
inverse relationship between type I IFN expression and the expression of pro-inflammatory 
genes in the context of WT- and IFN antagonist-deficient coronavirus infections. The 
mechanisms that contribute to the early attenuation of EndoU-mut-MHV replication and gene 
expression, including the role of apoptosis, also warrant further investigation.
ER Stress.
If early apoptosis might have contributed to the unique transcriptional profile that we 
obtained from EndoU-mut-MHV-infected BMDMs, what mechanism(s) could explain the 
markedly enhanced transcriptional activation of host genes that we observed in DUB-mut- and 
WT-MHV-infected cells? Why did DUB-mut- and WT-MHV-infected BMDMs exhibit the 
highest pro-inflammatory responses? Indeed, why did WT-MHV elicit such markedly amplified 
expression of so many genes in general? WT-MHV encodes multiple IFN antagonists, including 
a functional EndoU that, as we and others recently showed, is required for the evasion of 
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multiple cellular dsRNA sensors (Deng et al. 2017; Kindler et al. 2017). Therefore, we expected 
that impaired sensing of viral dsRNA in the context of WT-MHV infection would correspond to 
a limited host transcriptional response overall, but found precisely the opposite to be true. 
Having completed a literature search to address these questions, we now speculate that cellular 
stressors including mitochondrial oxidative stress and endoplasmic reticulum (ER) stress may 
have played a role in shaping the observed transcriptional responses to the viruses used in this 
study. Several groups have published compelling data demonstrating that coronaviruses induce 
substantial oxidative and ER stress during infection, which can have a number of outcomes, 
including the induction of pro-inflammatory cytokines, translation attenuation, and if left 
unresolved, eventual apoptosis (Mogensen et al. 2003; DeDiego et al. 2011; Fung and Liu 2014; 
Siu et al. 2014; Smith 2014; Reineke et al. 2015; Fung et al. 2016). In particular, it is 
increasingly clear that coronavirus-induced ER stress and the unfolded protein response that cells 
mount to alleviate such stress may activate NF-κB-mediated inflammation through multiple 
pathways, thereby possibly contributing to the transcriptomic profiles that we observed in this 
study.
ER stress is primarily caused by an accumulation of unfolded proteins within the ER (Xu 
et al. 2005; Smith 2014). Virus infections represent just one of several possible root causes of 
unfolded protein accumulation since the mass-production of virions using viral proteins places 
enormous strain on a host cell’s protein folding machinery (Xu et al. 2005; Smith 2014). Upon 
detecting ER stress through special sensing pathways within the ER, the cell initiates an unfolded 
protein response (UPR) in an effort to resolve the source of the stress; this UPR, in turn, can 
activate a pro-inflammatory response in a process that was recently referred to in one paper as “a 
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new paradigm” of innate immune sensing of viruses (Fung and Liu 2014; Smith 2014; Fung et 
al. 2016). The UPR comprises 3 known pathways, depicted in Figure 20. 
Figure 20. The Unfolded Protein Response. The UPR comprises 3 signaling pathways. In 
unstressed cells, the initiating members of these pathways—IRE1, ATF6, and PERK—are held 
in an inactive state by BiP, a folding chaperone protein. Each pathway is activated upon the 
release of BiP. (Left) IRE1 oligomerizes after releasing BiP, initiating a signaling cascade 
involving JNK and XBP1. (Middle) BiP release from ATF6 reveals a Golgi localization signal 
(GLS) in ATF6. Upon trafficking to the Golgi, ATF6 is cleaved to produce an active 
transcription factor. (Right) Once released from BiP, PERK attenuates most translation by 
phosphorylating eIF2α. In boxes are cellular processes regulated by the UPR, including 
apoptosis, ERAD (ER associated degradation), lipid synthesis, the expression of ER chaperones, 
etc. Used with permission from Smith (2014).
An evolving view of the 3 UPR pathways involves the addition of NF-κB and the 
expression of NF-κB-induced pro-inflammatory genes as a downstream consequence of UPR 
initiation. For example, PERK-mediated translation attenuation has been shown to activate NF-
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κB by reducing the protein levels of NF-κB inhibitor IκBα; it has also been proposed that PERK-
induced modulation of JNK and p38 (initiated by phosphorylation of eIF2α) may also regulate 
the expression of pro-inflammatory cytokines (Deng et al. 2004; Tam et al. 2012; Fung and Liu 
2014; Smith 2014). In a similar vein, several labs have published data collectively indicating that 
IRE1 activation synergistically augments the innate immune response by increasing the 
activation of NF-κB (Hu et al. 2011; Tam et al. 2012; Fung and Liu 2014; Smith 2014). 
Together, these findings point to a role for the ER stress-induced UPR in innate immunity.
Coronavirus infections may be particularly potent sources of ER stress and activators of 
the UPR due to the expression of their extremely large genomes and the subsequent folding of 
massive quantities of viral proteins, CoV-induced reorganization of ER membranes to generate 
the DMVs in which CoV replication complexes are assembled, and depletion of ER membranes 
during the budding of nascent virions (Fung and Liu 2014; Fung et al. 2016). Indeed, multiple 
groups have reported increased detection of ER stress and UPRs in cells infected with 
coronaviruses including MHV, SARS-CoV, HCoV-HKU1, MERS-CoV, and IBV (Raaben et al. 
2007; Bechill et al. 2008; DeDiego et al. 2011; Fung et al. 2014; Siu et al. 2014; Rabouw et al. 
2016; Irigoyen et al. 2018). Notably, MHV has been shown to activate all 3 UPR pathways 
during infection (Raaben et al. 2007; Bechill et al. 2008; Irigoyen et al. 2018). In the current 
study, using our RNA-seq data, we also detected activation of the UPR by 12 hpi based on 
increased expression of at least 9 genes that are known to be transcriptional targets of the PERK 
(Atf4, GADD153/CHOP/Ddit3, and Dusp1), IRE1 (Erdj4/Dnajb9, Edem1, and p58IPK/Dnajc3), 
and ATF6 (GRP78/BiP/Hspa5, GRP94/Hsp90b1, and Herpud1) pathways (Wu et al. 2007; Fung 






















































































































Figure 21. Expression of Genes Targeted by UPR Pathways in EndoU-mut-, DUB-mut-, 
and WT-MHV-infected BMDMs at 12 hpi. The normalized count values for 9 UPR-induced 
genes at 12 hpi are plotted. Genes are grouped into 3 panels according to whether their 
expression is triggered by (A) PERK, (B) IRE1, or (C) ATF6 pathway signaling. Data were 
subjected to statistical analysis by two-tailed Student’s t-tests. * p < 0.05; ** p < 0.01; *** p < 
0.001; **** p < 0.0001; ns, not significant. Data are presented as means ± SD.
The data in Figure 21 indicate that all 3 UPR pathways were substantially activated in 
DUB-mut- and WT-MHV-infected cells but relatively minimally activated in EndoU-mut-
infected cells relative to mock at 12 hpi. Two genes—Edem1 and GRP94/Hsp90b1—were not 
statistically significantly upregulated at all in EndoU-mut-infected cells relative to mock, 
suggesting an overall reduced activation of the UPR pathways by the EndoU-mut-MHV virus 
compared with the other two viruses. As other groups have previously shown, the apparent 
activation of these pathways in DUB-mut- and WT-MHV-infected cells was not associated with 
impaired replication of the viruses, as illustrated in Figure 11, suggesting that MHV—and 
perhaps other CoVs—has evolved to evade and/or suppress UPR-mediated antiviral activity, 
including UPR-induced apoptosis (Raaben et al. 2007; Bechill et al. 2008; Irigoyen et al. 2018). 
Indeed, it has been reported that several SARS-CoV-encoded proteins and at least one MERS-
CoV-encoded protein antagonize the ER stress response during infection, indicating that 
coronaviruses are capable of shaping the UPR to their own benefit (DeDiego et al. 2011; 
Rabouw et al. 2016).
It is an intriguing possibility that the results of our RNA-seq experiments in DUB-mut- 
and WT-MHV-infected BMDMs, which revealed robust expression of nearly 2,900 host genes in 
response to infection, might be explained at least in part by the ER stress-triggered UPR. If, for 
example, the infection prompted the UPR, as has been well documented, it is possible that the 
outcome of UPR pathway signaling led to the activation of NF-κB and the downstream 
expression of NF-κB-induced inflammatory genes all while evading the initiation of apoptosis, 
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as has also been demonstrated during CoV infections. In light of the results of our qRT-PCR 
experiments in Figure 12, which revealed that massive amounts of viral N gene transcript 
accumulated as early as 6 hpi during DUB-mut- and WT-MHV infection, a virus-induced wave 
of ER stress and the subsequent activation of the UPR would not be unusual. By activating the 
UPR, the cell’s response to this ER stress would have the potential to produce potently pro-
inflammatory macrophages via NF-κB-mediated gene expression. Prevented from undergoing 
apoptosis due to virus-encoded antagonists like nsp15-EndoU, these inflammatory macrophages 
might then contribute to the development of severe inflammatory coronaviral disease, in line 
with what has been reported in the literature (Cheung et al. 2005; Zhou et al. 2014; 
Channappanavar et al. 2016). Such a scenario could explain why the DUB-mut- and WT-MHV-
infected cells in this study exhibited unimpeded viral replication coupled with dramatically 
increased expression of pro-inflammatory genes compared to mock-infected cells. Conversely, 
we hypothesize that the EndoU-mut-MHV-infected cells were rapidly driven toward an apoptotic 
phenotype early during infection due to the inability of the mutant virus to evade detection by the 
PKR and OAS/RNase L pathways. Early initiation of apoptosis would, in turn, preclude the 
buildup of significant ER stress and the subsequent activation of a broad inflammatory response 
to EndoU-mut-MHV infection akin to what was observed in DUB-mut- or WT-MHV-infected 
cells. This proposed dichotomy is illustrated in Figure 22. The extensive increase in expression 
of thousands of genes that our RNA-seq experiments revealed in DUB-mut- and WT-MHV-
infected BMDMs likely cannot be attributed to ER stress-induced gene expression alone, but we 
speculate that the UPR played an important role in shaping at least part of the transcriptional 
profiles that we report here. At any rate, although additional work is required to fully elucidate 
the mechanism(s) that underlie the patterns of gene expression that we observed in this study, it 
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is remarkable that a single amino acid change in nsp15-EndoU—but not in nsp3-DUB—was 
sufficient to profoundly alter the fate of the virus and of EndoU-mut-MHV-infected BMDMs. 
Figure 22. Proposed Model of the Consequences of EndoU-mut-, DUB-mut-, and WT-MHV 
Infection in BMDMs. Upon infection of a BMDM with EndoU-mut-MHV, host dsRNA sensors 
(including RIG-I, MDA5, PKR, and OAS/RNase L) are activated, resulting in robust 
transcription of type I IFN genes and rapid induction of apoptosis, the latter of which precludes 
the development of a potent inflammatory response. Viral replication is severely restricted in 
these apoptotic macrophages (shriveled grey/black cell) as early as 6 hpi. Although DUB-mut-
MHV induces significantly higher type I IFN during infection than WT-MHV, infection with 
either DUB-mut- or WT-MHV results in the same outcome: accumulation of ER stress and 
subsequent activation of the UPR, which then likely contributes to the establishment of a robust 
NF-κB-mediated pro-inflammatory response. BMDMs infected with either of these viruses 
acquire a potently activated, inflammatory phenotype (orange cell), are unable to attenuate viral 



















Targeting CoV-encoded IFN Antagonists for Rational Vaccine Design 
Including nsp3-DUB and nsp15-EndoU, multiple coronavirus proteins—including both 
structural and nonstructural proteins—are reported to antagonize the innate immune response in 
vitro and/or in vivo. These include: nsp16-2’O MTase, nsp14-ExoN, nsp1, nsp7, E protein, N 
protein, M protein, SARS-CoV-ORF6, MERS-CoV-ORF3-5, MERS-CoV-4a, and others 
(Frieman et al. 2007; Frieman et al. 2009; DeDiego et al. 2014; Rabouw et al. 2016; Menachery, 
Galinski, et al. 2017; Menachery, Mitchell, et al. 2017; Menachery et al. 2018). The very nature 
of this ever-growing list suggests that CoVs might encode a hierarchy of innate immune 
antagonists that collectively target both shared and unique factors and pathways during infection. 
The data from this study and our previous work strongly indicate that nsp15-EndoU activity 
might sit at the top, or near the top, of such a hierarchy since it is evidently indispensable for 
successful infection both in vitro and in vivo, while nsp3-DUB might sit near the bottom rung of 
the ladder given that its activity does not appear to be similarly required (Deng et al. 2017; Deng 
et al. manuscript in preparation). Additionally, it is clear from the results of our RNA-seq 
experiments that the absence of nsp15-EndoU activity induced widespread changes in host gene 
expression relative to WT-MHV infection, whereas DUB-mut-MHV-infected cells elicited only 
a slightly altered transcriptional response compared to WT-MHV. These data also support the 
notion that nsp15-EndoU is a “master” regulator of the host response, whereas nsp3-DUB 
activity likely acts on a select number of targets to supplement nsp15-EndoU-mediated 
antagonism. Although additional work is required to clarify the roles of the many CoV-encoded 
innate immune antagonists relative to each other in the context of infection, that these viral 
proteins might work together in a hierarchical manner to achieve potent suppression of the 
antiviral response opens the door to new strategies for live-attenuated vaccine development.
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Combinatorial Approach to Generating IFN Antagonist-deficient CoV Vaccines.
Targeting viral IFN antagonists for the rational design of live-attenuated vaccines is an 
increasingly popular idea among virologists. In some cases, it is no longer merely an idea: 
recently-published reports have demonstrated remarkable efficacy of IFN antagonist-deficient 
MHV, MERS-CoV, SARS-CoV, and influenza A viruses as vaccine candidates (Deng et al. 
2017; Menachery, Galinski, et al. 2017; Du et al. 2018; Menachery et al. 2018). Two of these 
studies reported using a combinatorial approach to generating live-attenuated, IFN-sensitive 
vaccine strains by disrupting multiple IFN antagonists within the same strain. Using a mouse-
adapted SARS-CoV strain, Menachery et al. (2018) demonstrated that combining a mutation in 
nsp16-2’O MTase with an additional mutation in nsp14-ExoN resulted in robust protection from 
subsequent challenge with WT-SARS-CoV in mice without causing demonstrable pathogenesis. 
Similarly, Du et al. (2018) reported that combining 8 total “IFN-sensitive” mutations across the 
genome of the influenza A virus yielded a “hyper-IFN-sensitive (HIS)” vaccine strain that could 
be replicated to high titers in vitro but was markedly attenuated and induced appreciable humoral 
and cellular immune responses in mice (Du et al. 2018). Importantly, a combinatorial approach 
to rational vaccine design offers the advantage of reducing the likelihood of reversion to WT-like 
virulence, which is of particular concern when generating live-attenuated vaccine candidates.
The results of this study indicate that nsp15-EndoU and nsp3-DUB are attractive targets 
for the generation of a combination vaccine candidate. We observed that EndoU-mut-MHV was 
remarkably attenuated in macrophages, in line with our previously-published work in vitro and in 
vivo, and elicited a significantly diminished transcriptional response overall, including among 
groups of genes encoding potently pro-inflammatory and chemotactic proteins whose 
overexpression in the context of WT infection is thought to contribute to the severity of 
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coronaviral disease pathology (Deng et al. 2017). On the other hand, replication of DUB-mut-
MHV was not attenuated, despite inducing a considerably increased type I IFN response relative 
to WT-MHV infection, and differentially impacted the expression of only a few genes relative to 
the parental strain. Therefore, we intend to combine these two mutations in the near future to 
produce a vaccine candidate that, deficient in two of its IFN antagonism activities, is both safe 
and even more effective in vivo than the EndoU-mutant strain. Very preliminary data from our 
lab indicate that this approach might hold considerable promise, although substantial work 
remains to be completed. In conclusion, the work that we report here strongly suggests that 
combining mutations in nsp3-DUB and nsp15-EndoU with additional mutations in still other 
conserved CoV-encoded innate immune antagonists—perhaps nsp14-ExoN and nsp16-2’O-
MTase, for example—might represent the most promising and universally-effective strategy yet 





Table S1. List of Gene Names in Order of Appearance in Figure 14. Listed are the names of 
the 2,879 genes whose expression profiles are plotted in the heatmap in Figure 14. To preserve 
the order of the genes as they appear from top to bottom in Figure 14, this list should be read left 
to right, one row after another. In bold type after each gene name is the DESeq2-generated log2 
fold-change value associated with the increase in expression of each gene in WT-MHV-infected 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table S2. List of 30 Unique Genes in Statistically Significant Functional Clusters within 












Table S3. List of 151 Unique Genes in Statistically Significant Functional Clusters within 























































Table S4. List of 203 Unique Genes in Statistically Significant Functional Clusters within 







































































Table S5. List of 149 Unique Genes in Statistically Significant Functional Clusters Within 
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